Patent Grant
11002123
This application claims priority from Canadian Patent Application 2,978,157 filed 31 Aug. 2017 entitled THERMAL RECOVERY METHODS FOR RECOVERING VISCOUS HYDROCARBONS FROM A SUBTERRANEAN FORMATION, the entirety of which is incorporated by reference herein.
The present disclosure is directed generally to thermal recovery methods of recovering viscous hydrocarbons from a subterranean formation and more particularly to thermal recovery methods that sequentially inject a heated solvent vapor stream and a steam stream into the subterranean formation.
Hydrocarbons often are utilized as fuels and/or as chemical feedstocks for manufacturing industries. Hydrocarbons naturally may be present within subterranean formations, which also may be referred to herein as reservoirs and/or as hydrocarbon reservoirs. Such hydrocarbons may occur in a variety of forms, which broadly may be categorized herein as conventional hydrocarbons and unconventional hydrocarbons. A process utilized to remove a given hydrocarbon from a corresponding subterranean formation may be selected based upon one or more properties of the hydrocarbon and/or of the subterranean formation.
Examples of hydrocarbon production techniques that may be utilized to produce viscous hydrocarbons from a subterranean formation include thermal recovery processes. Thermal recovery processes generally inject a thermal recovery stream, at an elevated temperature, into the subterranean formation. The thermal recovery stream contacts the viscous hydrocarbons, within the subterranean formation, and heats, dissolves, and/or dilutes the viscous hydrocarbons, thereby generating mobilized viscous hydrocarbons. The mobilized viscous hydrocarbons generally have a lower viscosity than a viscosity of the naturally occurring viscous hydrocarbons at the native temperature and pressure of the subterranean formation and may be pumped and/or flowed from the subterranean formation. A variety of different thermal recovery processes have been utilized, including cyclic steam stimulation processes, solvent-assisted cyclic steam stimulation processes, steam flooding processes, solvent-assisted steam flooding processes, steam-assisted gravity drainage processes, solvent-assisted steam-assisted gravity drainage processes, heated vapor extraction processes, liquid addition to steam to enhance recovery processes, and/or near-azeotropic gravity drainage processes.
Thermal recovery processes may differ in the mode of operation and/or in the composition of the thermal recovery stream. However, all thermal recovery processes rely on injection of the thermal recovery stream into the subterranean formation, at the elevated temperature, and thermal contact between the thermal recovery stream and the subterranean formation heats the subterranean formation.
In thermal recovery processes, such as heated vapor extraction, that utilize a solvent, or a hydrocarbon solvent, as the thermal recovery stream, solvent loss to the subterranean formation may increase production costs and/or limit production economies. As an example, a decrease in an amount of solvent needed to produce viscous hydrocarbons from the subterranean formation may cause a corresponding decrease in production costs as long as the savings associated with the decrease in solvent utilization is not offset by a corresponding increase in energy consumption.
In addition, recovered solvent generally is separated from the viscous hydrocarbons and re-injected into the subterranean formation, and increases in a volume of the solvent recycled also may increase production costs and/or limit production economies. As another example, a decrease in the volume of solvent produced from the subterranean formation may permit a corresponding decrease in surface facility size required for solvent separation, recovery, and re-injection, also decreasing production costs.
Historically, thermal recovery processes may utilize solvent inefficiently within the subterranean formation, leading to increased solvent loss to the subterranean formation and/or increased production of solvent from the subterranean formation. Thus, there exists a need for improved thermal recovery methods for recovering viscous hydrocarbons from a subterranean formation.
Thermal recovery methods for recovering viscous hydrocarbons from a subterranean formation. The thermal recovery methods include performing a plurality of injection cycles. Each injection cycle in the plurality of injection cycles includes injecting a heated solvent vapor stream into a heated chamber that extends within the subterranean formation. The heated solvent vapor stream is injected via an at least substantially horizontal region of an injection well that extends within the heated chamber and for a heated solvent vapor injection time period. Each injection cycle also includes fluidly contacting the viscous hydrocarbons with the heated solvent vapor stream to generate a chamber liquid and/or mobilized viscous hydrocarbons. Each injection cycle further includes injecting a steam stream into the heated chamber. The steam stream is injected via the at least substantially horizontal region of the injection well and for a steam injection time period. The thermal recovery methods further include producing the chamber liquid and/or the mobilized viscous hydrocarbons from the subterranean formation. The producing may be performed during at least one injection cycle of the plurality of injection cycles.
Injection well 30 includes an injection wellhead 32 and an injection wellbore 34. Similarly, production well 40 includes a production wellhead 42 and a production wellbore 44.
During operation of hydrocarbon production system 10, injection well 30 may be utilized to provide, to supply, and/or to inject an injectant stream 60 into subterranean formation 24. Injectant stream 60 may include a heated solvent vapor stream 62 and/or a steam stream 64. Injectant stream 60 may interact with, contact, physically contact, fluidly contact, mix with, and/or heat viscous hydrocarbons 26, within subterranean formation 24, thereby producing, generating, and/or forming mobilized viscous hydrocarbons 72 within the subterranean formation. The mobilized viscous hydrocarbons may form a portion of a chamber liquid 70, which also may include a condensed fraction of injectant stream 60, such as a condensed fraction of the heated solvent vapor stream and/or a condensed fraction of the steam stream. Chamber liquid 70, including mobilized viscous hydrocarbons 72, may flow, under the influence of gravity, to production well 40, which may produce the chamber liquid and/or the mobilized viscous hydrocarbons from the subterranean formation.
Injection of injectant stream 60 into the subterranean formation and production of chamber liquid 70 from the subterranean formation may produce and/or generate a heated chamber 50 within the subterranean formation. The heated chamber may grow, with time, such as may be responsive to continued injection of the injectant stream and/or continued production of the chamber liquid. Heated chamber 50 and subterranean formation 24 may form and/or define an interface region 52 therebetween.
As schematically illustrated in dashed lines in
As also schematically illustrated in dashed lines in
As discussed in more detail herein with reference to methods 100 of
The steam stream generally will have a higher temperature, and a higher concentration of thermal energy, when compared to the corresponding properties of the heated solvent vapor stream. Stated another way, a steam temperature, at which the steam stream has a given vapor pressure, may be greater than a solvent vapor temperature, at which the heated solvent vapor stream has the same given vapor pressure. In addition, a heat capacity and/or a heat of vaporization of the steam stream may be greater than a heat capacity and/or a heat of vaporization of the heated solvent vapor stream. As such, injection of the steam stream into subterranean formation 24 and/or into heated chamber 50 may vaporize condensed solvent that comes into contact with the steam stream.
This vaporization of condensed solvent may provide several benefits over thermal recovery processes that inject the heated solvent vapor stream but that do not subsequently, and cyclically, inject the steam stream. As an example, vaporization of the condensed solvent within the heated chamber, thereby re-forming the heated solvent vapor stream within the heated chamber, may improve and/or increase supply of the heated solvent vapor stream to interface region 52. This may improve the efficiency of solvent utilization within the subterranean formation and/or may decrease a volume of condensed solvent produced from the subterranean formation and provided to surface facilities 90. As another example, vaporization of the condensed solvent within the heated chamber may decrease a potential for loss of the condensed solvent within the heated chamber by providing a driving force for production of the condensed solvent from the subterranean formation via production well 40.
With the above in mind,
As may be seen from
As may be seen from
The combination of
Forming one or more wells at 105 may include forming any suitable type, number, and/or configuration of well in any suitable manner. The well may form a portion of a hydrocarbon production system, such as hydrocarbon production system 10 of
Injecting the heated solvent vapor stream at 110 may include injecting any suitable heated solvent vapor stream into the subterranean formation and/or into a heated chamber that extends within the subterranean formation. The injecting at 110 may include injecting with, via, and/or utilizing the injection well and/or the horizontal region of the injection well.
The injecting at 110 also may include injecting for a heated solvent vapor injection time period. Examples of the heated solvent vapor injection time period include heated solvent vapor injection time periods of at least 0.1 days, at least 0.25 days, at least 0.5 days, at least 1 day, at least 2 days, at least 3 days, at least 4 days, at least 5 days, at least 6 days, at least 8 days, at least 10 days, at least 15 days, at least 20 days, at least 25 days, and/or at least 30 days. Additional examples of the heated solvent vapor injection time period include heated solvent vapor injection time periods of at most 45 days, at most 40 days, at most 35 days, at most 30 days, at most 25 days, at most 20 days, at most 15 days, at most 10 days, and/or at most 5 days.
The heated solvent vapor stream may have and/or define any suitable composition or chemical composition that includes at least 50 weight percent nonaqueous species, which also may be referred to herein as a solvent. The nonaqueous species non-negligibly solubilizes and/or dissolves the viscous hydrocarbons and may include a hydrocarbon, or a hydrocarbon solvent, examples of which are disclosed herein. As an example, the heated solvent vapor stream may consist of, or consist essentially of the nonaqueous species. As another example, the heated solvent vapor stream may include at least a threshold fraction of the nonaqueous species. Examples of the threshold fraction of nonaqueous species include threshold fractions of at least 50 weight percent (wt %), at least 51 wt %, at least 60 wt %, at least 70 wt %, at least 80 wt %, at least 90 wt %, at least 95 wt %, and/or at least 99 wt %. As more specific examples, the heated solvent vapor stream and/or the nonaqueous species may include, consist of, and/or consist essentially of one or more of a hydrocarbon, a hydrocarbon solvent, an alkane, an alkene, an alkyne, an aliphatic compound, a naphthenic compound, an aromatic compound, an olefinic compound, natural gas condensate, liquefied petroleum gas, and/or a crude oil refinery stream.
The heated solvent vapor stream also may include water and/or steam. As an example, the heated solvent vapor stream may include an azeotropic, or a near-azeotropic, mixture of hydrocarbon solvent and water. Under these conditions, a solvent molar fraction of the hydrocarbon solvent in the near-azeotropic mixture may be 70%-130% of an azeotropic molar fraction of the near-azeotropic mixture at the target operating pressure within the heated chamber.
It is within the scope of the present disclosure that a bubble point temperature of the heated solvent vapor stream at the target operating pressure within the heated chamber may be less than a bubble point temperature of the steam stream at the target operating pressure within the heated chamber. As such, and as discussed in more detail herein, the injecting at 140 may facilitate vaporization of condensed solvent within the heated chamber.
It is within the scope of the present disclosure that the injecting at 110 may be performed in a manner that is similar to that of more conventional solvent-based thermal recovery processes. As examples, the injecting at 110 may be performed in a manner that is similar to, or may be performed as part of, a heated vapor extraction process, an azeotropic heated vapor extraction process, and/or a near-azeotropic heated vapor extraction process.
The injecting at 110 is illustrated schematically in
Fluidly contacting viscous hydrocarbons with the heated solvent vapor stream at 115 may include fluidly contacting to produce and/or generate mobilized viscous hydrocarbons within the heated chamber. This may be accomplished in any suitable manner. As examples, the fluidly contacting at 115 may include one or more of diluting the viscous hydrocarbons with the heated solvent vapor stream to generate the mobilized viscous hydrocarbons, dissolving the viscous hydrocarbons in the heated solvent vapor stream to generate the mobilized viscous hydrocarbons, and/or heating the viscous hydrocarbons with the heated solvent vapor stream to generate the mobilized viscous hydrocarbons.
The fluidly contacting at 115 also is schematically illustrated in
Condensing the heated solvent vapor stream at 120 may include condensing the heated solvent vapor stream to produce and/or form condensed solvent and/or to form the chamber liquid that includes both the condensed solvent and the mobilized viscous hydrocarbons. The condensing at 120 may be facilitated by, responsive to, and/or a result of the fluidly contacting at 115. As an example, and as discussed, the fluidly contacting at 115 may include heating the viscous hydrocarbons to generate the mobilized viscous hydrocarbons. Under these conditions, heating of the viscous hydrocarbons may be accompanied by a corresponding decrease in a temperature of the heated solvent vapor stream, thereby causing the heated solvent vapor stream to release its heat of condensation and transition from the vapor phase to the liquid phase.
Additionally or alternatively, the condensing at 120 may be facilitated by, responsive to, and/or a result of thermal and/or fluid contact between the heated solvent vapor stream and subterranean strata that extends within the heated chamber. As an example, thermal and/or fluid contact between the heated solvent vapor stream and the subterranean strata may facilitate thermal energy transfer from the heated solvent vapor stream to the subterranean strata, thereby causing the heated solvent vapor stream to condense on the subterranean strata and generate the condensed solvent.
Accumulating chamber liquid at 125 may include accumulating the chamber liquid within the heated chamber. This may include accumulating the chamber liquid, which may include both the condensed solvent and the mobilized viscous hydrocarbons, to form a chamber liquid pool within the heated chamber. Additionally or alternatively, the accumulating at 125 may include accumulating the chamber liquid such that, or until, the at least substantially horizontal region of the injection well is at least partially immersed, is immersed, is completely immersed, is at least partially covered, is covered, and/or is completely covered by the chamber liquid and/or within the chamber liquid pool.
Stated another way, the accumulating at 125 may include accumulating such that the at least substantially horizontal region of the injection well is below, or is a threshold di stance below, an upper surface of the chamber liquid pool. Examples of the threshold distance include threshold distances of at least 0.5 meters, at least 1 meter, at least 2 meters, at least 3 meters, at least 4 meters, at most 8 meters, at most 6 meters, and/or at most 4 meters.
The accumulating at 125 may be accomplished in any suitable manner. As an example, methods 100 may include ceasing the producing at 160, such as to bring about, or facilitate, the accumulating at 125. As another example, methods 100 may include regulating a production rate of a produced chamber liquid that is produced during the producing at 155 to bring about, or facilitate, the accumulating at 125. As a more specific example, the accumulating at 125 may include increasing the production rate of the produced chamber liquid responsive to the upper surface of the chamber liquid pool being above, or being greater than the threshold distance above, the at least substantially horizontal region of the injection well. As another more specific example, the accumulating at 125 may include decreasing the production rate of the produced chamber liquid responsive to the upper surface of the chamber liquid pool being below, or being less than the threshold distance above, the at least substantially horizontal region of the injection well.
The accumulating at 125 is schematically illustrated in
Monitoring the liquid level variable at 130 may include monitoring any suitable liquid level variable that may be associated with and/or indicative of a location of the upper surface of the chamber liquid pool within the heated chamber. When methods 100 include the monitoring at 130, the accumulating at 125 may be performed based, at least in part, on the liquid level variable. As an example, the accumulating at 125 may include increasing a height of a liquid level of the chamber liquid pool and/or a depth of the chamber liquid pool, within the heated chamber, until the monitoring at 130 indicates that the at least substantially horizontal region of the injection well is immersed within the chamber liquid. Examples of the liquid level variable include one or more of a pressure within the heated chamber, a pressure differential within the heated chamber, a pressure differential between the injection well and the production well, a pressure differential between two different depths within the heated chamber, a temperature within the heated chamber, a temperature differential within the heated chamber, a production temperature of the produced fluid stream, a temperature differential between a temperature of the heated solvent vapor stream and a temperature of the produced fluid stream, a temperature differential between the temperature of the produced fluid stream and a bubble point temperature of the heated solvent vapor stream, a temperature differential between the temperature of the produced fluid stream and a dew point temperature of the heated solvent vapor stream, a comparison between the temperature within the heated chamber and an estimated bubble point temperature of the chamber liquid, a change in a production temperature of mobilized viscous hydrocarbons, the production temperature of the mobilized viscous hydrocarbons, and/or a water-to-hydrocarbon ratio within the produced chamber liquid.
Ceasing injection of the heated solvent vapor stream at 135 may be performed with any suitable timing within methods 100 and/or in any suitable manner. As an example, the ceasing at 135 may include ceasing injection of the heated solvent vapor stream subsequent to the heated solvent vapor injection time period and/or subsequent to performing the injecting at 110 for the heated solvent vapor injection time period. As another example, the ceasing at 135 may include ceasing injection of the heated solvent vapor stream prior to the steam injection time period and/or prior to initiation of the injecting at 140.
Injecting the steam stream at 140 may include injecting the steam stream via the at least substantially horizontal region of the injection well and/or into the heated chamber. The injecting at 140 may include injecting the steam stream subsequent to performing the injecting at 110, injecting the steam stream subsequent to the heated solvent vapor injection time period, and/or injecting the steam stream for a steam injection time period.
It is within the scope of the present disclosure that the injecting at 140 may include vaporizing, or injecting the steam stream to vaporize, at least a fraction of the condensed solvent that is present within the heated chamber. Additionally or alternatively, the injecting at 140 may include vaporizing, or injecting the steam stream to vaporize, at least a fraction of the chamber liquid that may extend within the heated chamber and/or that may define the chamber liquid pool. This may include vaporizing the condensed solvent and/or the chamber liquid to produce and/or generate vaporized solvent.
As discussed herein, the heated chamber may include and/or define an interface region that extends between the heated chamber and a remainder of the subterranean formation. Under these conditions, the injecting at 140 may include injecting the steam stream to facilitate, or provide a motive force for, flow of the heated solvent vapor stream and/or the vaporized solvent toward and/or into contact with the interface region.
This is illustrated schematically in
When methods 100 include the accumulating at 125, the injecting at 140 additionally or alternatively may include injecting, or initiating the injecting, subsequent to the accumulating at 125 and/or subsequent to the at least substantially horizontal region of the injection well being immersed within the chamber liquid. Stated another way, the accumulating at 125 may be performed prior to the injecting at 140. Under these conditions, the injecting at 140 may include injecting such that the steam stream contacts, directly contacts, flows through, and/or bubbles through at least a region of the chamber liquid pool. Additionally or alternatively, the injecting at 140 may include injecting such that the steam stream vaporizes at least a fraction of the chamber liquid, such as the condensed solvent, from the chamber liquid pool. When methods 100 include the accumulating at 125, methods 100 further may include maintaining the at least substantially horizontal region of the injection well immersed within the chamber pool during the injecting at 140, during the steam injection time period, during at least a substantial fraction of the steam injection time period, during a majority of the steam injection time period, and/or during an entirety of the steam injection time period.
This is illustrated schematically in
It is within the scope of the present disclosure that methods 100 may transition between the injecting at 110 to the injecting at 140 based upon any suitable criteria. As an example, the heated solvent vapor injection time period may be a predetermined, or fixed, heated solvent vapor injection time period. Under these conditions, methods 100 may transition from the injecting at 110 to the injecting at 140 subsequent to, or subsequent to expiration of, the heated solvent vapor injection time period.
Additionally or alternatively, the heated solvent vapor injection time period may be determined and/or established based, at least in part, upon one or more properties and/or variables that may be determined and/or measured during methods 100. Stated another way, methods 100 may transition from the injecting at 110 to the injecting at 140 based, at least in part, on the one or more properties and/or variables. Examples of the one or more properties and/or variables include a change in a production rate of mobilized viscous hydrocarbons from the subterranean formation during the producing at 155; in the production rate, or a magnitude of the production rate, of the mobilized viscous hydrocarbons; in a concentration of solvent in the mobilized viscous hydrocarbons produced from the subterranean formation; in the concentration, or a magnitude of the concentration, of the solvent, and/or in a temperature within the heated chamber.
The steam injection time period may have any suitable duration. As examples, the steam injection time period may be at least 0.1 days, at least 0.25 days, at least 0.5 days, at least 0.75 days, at least 1 day, at least 1.5 days, at least 2 days, at least 3 days, at least 4 days, at least 5 days, at least 6 days, at least 8 days, at least 10 days, and/or at least 15 days. Additionally or alternatively, the steam injection time period may be at most 15 days, at most 10 days, at most 8 days, at most 6 days, at most 5 days, at most 4 days, at most 3 days, at most 2 days, and/or at most 1 day.
Additionally or alternatively, the heated solvent vapor injection time period and the steam injection time period may have any suitable relative magnitude. As an example, method 100 may define an injection time ratio of the heated solvent vapor injection time period to the steam injection time period. Examples of the injection time ratio include injection time ratios of at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 8, at least 10, at least 15, at least 20, at least 25, at least 30, at least 40, and/or at least 50. Additionally or alternatively, the injection time ratio may be at most 100, at most 80, at most 60, at most 50, at most 40, at most 30, at most 25, at most 20, at most 15, and/or at most 10. The injection time ratio may be selected to prevent, or to decrease a potential for, fluid contact between the steam stream and the interface region.
Additionally or alternatively, methods 100 may define an injection mass ratio. As an example, the injecting at 110 may include injecting a mass of heated solvent vapor, the injecting at 140 may include injecting a mass of steam, and the injection mass ratio may be a ratio of the mass of heated solvent vapor to the mass of steam. The injecting at 110 and the injecting at 140 may be performed such that the injection mass ratio has any suitable value, or magnitude. As examples, the injection mass ratio may be at least 1, at least 1.25, at least 1.5, at least 2, at least 3, at least 4, at least 6, at least 8, at least 10, at least 12.5, at least 15, at least 20, at least 25, and/or at least 30. Additionally or alternatively, the injection mass ratio may be at most 100, at most 80, at most 60, at most 50, at most 40, at most 30, at most 25, at most 20, at most 15, and/or at most 10.
The injecting at 140 may include injecting a steam stream with any suitable composition. As an example, the steam stream may include, may consist of, and/or may consist essentially of steam and/or water. As another example, the steam stream may include, have, and/or define at least a threshold fraction of steam. Examples of the threshold fraction of steam include threshold fractions of at least 51 wt %, at least 60 wt %, at least 70 wt %, at least 80 wt %, at least 90 wt %, at least 95 wt %, and/or at least 99 wt %. Ceasing injection of the steam stream at 145 may include ceasing supply of the steam stream to the subterranean formation and/or to the heated chamber via the injection well. Stated another way, the ceasing at 145 may include ceasing the injecting at 140.
The ceasing at 145 may be performed subsequent to the steam injection time period and/or prior to the repeating at 180. Stated another way, and within a given injection cycle of the plurality of injection cycles, the ceasing at 145 may be performed prior to performing the injecting at 110 for a subsequent injection cycle of the plurality of injection cycles.
Draining mobilized viscous hydrocarbons at 150 may include draining the mobilized viscous hydrocarbons under the influence of gravity. This may include draining the mobilized viscous hydrocarbons toward and/or into a lower region of the heated chamber that includes the at least substantially horizontal region of the production well. Additionally or alternatively, the draining at 150 may include draining the mobilized viscous hydrocarbons toward and/or into the production well. This is illustrated schematically in
Producing the produced fluid stream at 155 may include producing the chamber liquid, the mobilized viscous hydrocarbons, and/or the condensed solvent from the heated chamber and/or from the subterranean formation. This may include producing with, via, and/or utilizing the production well, or the at least substantially horizontal region of the production well. The chamber liquid may be produced from the subterranean formation as a produced chamber liquid. Similarly, the mobilized viscous hydrocarbons may be produced from the subterranean formation as produced mobilized viscous hydrocarbons, and/or the condensed solvent may be produced from the subterranean formation as produced condensed solvent.
The producing at 155 may be performed with any suitable timing and/or sequence during methods 100. As an example, the producing at 155 may be performed during at least one injection cycle of the plurality of injection cycles. As another example, the producing at 155 may be performed during each injection cycle of the plurality of injection cycles. As yet another example, the producing at 155 may be performed during at least a portion of the heated solvent vapor injection time period, during an entirety of the heated solvent vapor injection time period, during the injecting at 110, during the fluidly contacting at 115, during at least a portion of the steam injection time period, during an entirety of the steam injection time period, and/or during the injecting at 140. Stated another way, it is within the scope of the present disclosure that methods 100 may include continuously performing the producing at 155 or intermittently performing the producing at 155. When methods 100 include intermittently performing the producing at 155, methods 100 may include ceasing the producing at 160 prior to the injecting at 140 and/or during the injecting at 140, such as to facilitate the accumulating at 125, when performed.
As discussed herein, the at least substantially horizontal region of the production well may extend within the heated chamber and below the at least substantially horizontal region of the injection well. It is within the scope of the present disclosure that the at least substantially horizontal region of the production well and the at least substantially horizontal region of the injection well may define any suitable spacing, or average spacing, therebetween. In addition, and when methods 100 include the forming at 105, the forming at 105 may include forming such that the at least substantially horizontal region of the production well and the at least substantially horizontal region of the injection well have and/or define the average spacing. Examples of the average spacing include average spacings of at least 1 meter, at least 2 meters, at least 3 meters, at least 4 meters, at least 5 meters, at most 10 meters, at most 8 meters, at most 5 meters, at most 4 meters, at most 3 meters, and/or at most 2 meters.
Reducing the volume of chamber liquid at 165 may include reducing the volume of chamber liquid within, or that defines, the chamber liquid pool. Stated another way, the reducing at 165 may include reducing the volume of chamber liquid within the heated chamber. This may include reducing such that the at least substantially horizontal region of the injection well extends above, or is not immersed in, the chamber liquid pool.
The reducing at 165 may be performed at any suitable time and/or with any suitable sequence during methods 100. As an example, methods 100 may include performing the reducing at 165 subsequent to performing the injecting at 140. As another example, and within each injection cycle of the plurality of injection cycles, methods 100 may include performing the reducing at 165 prior to performing the injecting at 110.
Maintaining the target operating pressure at 170 may include maintaining the target operating pressure in, or within, the heated chamber. This may include performing the injecting at 110 at, or to maintain, the target operating pressure and/or performing the injecting at 140 at, or to maintain, the target operating pressure. Additionally or alternatively, the maintaining at 170 may include selectively varying a temperature of the heated solvent vapor stream and/or a temperature of the steam stream to maintain the target operating pressure within the heated chamber.
Monitoring the composition variable at 175 may include monitoring any suitable composition variable that may be associated with a solvent content of the produced chamber liquid. Examples of the composition variable include a density of the produced chamber liquid, a viscosity of the produced chamber liquid, and/or a chemical composition of the produced chamber liquid.
When methods 100 include the monitoring at 175, methods 100 also may include selectively regulating the injecting at 110 based, at least in part, on the monitoring at 175. As an example, methods 100 may include selectively regulating an injection rate of the heated solvent vapor stream based, at least in part, on the composition variable. This may include selectively increasing the injection rate of the heated solvent vapor stream responsive to a decrease in the solvent content of the produced chamber liquid and/or selectively increasing the injection rate of the heated solvent vapor stream responsive to an increase in the solvent content of the produced chamber liquid.
When methods 100 include the monitoring at 175, methods 100 also may include selectively regulating the injecting at 140 based, at least in part, on the monitoring at 175. As an example, methods 100 may include selectively regulating an injection rate of the steam stream based, at least in part, on the composition variable. This may include selectively increasing the injection rate of the steam stream responsive to an increase in the solvent content of the produced chamber liquid and/or selectively decreasing the injection rate of the steam stream responsive to a decrease in the solvent content of the produced chamber liquid.
When methods 100 include the monitoring at 175, methods 100 also may include selectively regulating the producing at 155 based, at least in part, on the monitoring at 175. As an example, methods 100 may include selectively regulating a production rate of the chamber liquid based, at least in part, on the composition variable. This may include selectively increasing the production rate of the chamber liquid to decrease the volume of chamber liquid within the heated chamber and/or selectively decreasing the production rate of the chamber liquid to increase the volume of the chamber liquid within the heated chamber.
Repeating the methods for the plurality of injection cycles at 180 may include repeating at least the injecting at 110, the fluidly contacting at 115, and the injecting at 140 during each of the plurality of injection cycles. Stated another way, methods 100 may include sequentially performing the injecting at 110, the fluidly contacting at 115, and the injecting at 140 for a plurality of distinct injection cycles. The repeating at 180 also may include repeating the producing at 155 during each of the plurality of injection cycles.
It is within the scope of the present disclosure that methods 100 may include transition from a given injection cycle of the plurality of injection cycles to a subsequent injection cycle of the plurality of injection cycles based upon any suitable criteria. As an example, methods 100 may transition from the given injection cycle to the subsequent injection cycle responsive to completion of the injecting at 140 and/or responsive to expiration of the steam injection time period. As another example, methods 100 may include ceasing the injecting at 140, and/or transitioning from the given injection cycle to the subsequent injection cycle, responsive to the composition variable associated with the solvent content of the produced chamber liquid indicating less than a threshold solvent content within the produced chamber liquid.
It also is within the scope of the present disclosure that methods 100 may include modifying the injecting at 110 and/or the injecting at 140 in a given injection cycle of the plurality of injection cycles relative to a prior injection cycle of the plurality of injection cycles. As an example, and as discussed herein, performing methods 100 may cause the heated chamber to grow, or expand, with time. As such, and responsive to an increase in a volume of the heated chamber, methods 100 may include increasing the injection time ratio in the given injection cycle relative to the prior injection cycle. As additional examples, methods 100 may include modifying the injection time ratio in the given injection cycle relative to the prior injection cycle based, at least in part, on a change in a production rate of mobilized viscous hydrocarbons, on the production rate of mobilized viscous hydrocarbons, on a change in a concentration of solvent in the mobilized viscous hydrocarbons produced from the subterranean formation, on the concentration of the mobilized viscous hydrocarbons produced from the subterranean formation, on a temperature within the heated chamber, on a change in a production temperature of the mobilized viscous hydrocarbons, and/or on the production temperature of the mobilized viscous hydrocarbons.
In the present disclosure, several of the illustrative, non-exclusive examples have been discussed and/or presented in the context of flow diagrams, or flow charts, in which the methods are shown and described as a series of blocks, or steps. Unless specifically set forth in the accompanying description, it is within the scope of the present disclosure that the order of the blocks may vary from the illustrated order in the flow diagram, including with two or more of the blocks (or steps) occurring in a different order and/or concurrently.
As used herein, the term “and/or” placed between a first entity and a second entity means one of (1) the first entity, (2) the second entity, and (3) the first entity and the second entity. Multiple entities listed with “and/or” should be construed in the same manner, i.e., “one or more” of the entities so conjoined. Other entities may optionally be present other than the entities specifically identified by the “and/or” clause, whether related or unrelated to those entities specifically identified. Thus, as a non-limiting example, a reference to “A and/or B,” when used in conjunction with open-ended language such as “comprising” may refer, in one embodiment, to A only (optionally including entities other than B); in another embodiment, to B only (optionally including entities other than A); in yet another embodiment, to both A and B (optionally including other entities). These entities may refer to elements, actions, structures, steps, operations, values, and the like.
As used herein, the phrase “at least one,” in reference to a list of one or more entities should be understood to mean at least one entity selected from any one or more of the entities in the list of entities, but not necessarily including at least one of each and every entity specifically listed within the list of entities and not excluding any combinations of entities in the list of entities. This definition also allows that entities may optionally be present other than the entities specifically identified within the list of entities to which the phrase “at least one” refers, whether related or unrelated to those entities specifically identified. Thus, as a non-limiting example, “at least one of A and B” (or, equivalently, “at least one of A or B,” or, equivalently “at least one of A and/or B”) may refer, in one embodiment, to at least one, optionally including more than one, A, with no B present (and optionally including entities other than B); in another embodiment, to at least one, optionally including more than one, B, with no A present (and optionally including entities other than A); in yet another embodiment, to at least one, optionally including more than one, A, and at least one, optionally including more than one, B (and optionally including other entities). In other words, the phrases “at least one,” “one or more,” and “and/or” are open-ended expressions that are both conjunctive and disjunctive in operation. For example, each of the expressions “at least one of A, B, and C,” “at least one of A, B, or C,” “one or more of A, B, and C,” “one or more of A, B, or C,” and “A, B, and/or C” may mean A alone, B alone, C alone, A and B together, A and C together, B and C together, A, B and C together, and optionally any of the above in combination with at least one other entity.
As used herein the terms “adapted” and “configured” mean that the element, component, or other subject matter is designed and/or intended to perform a given function. Thus, the use of the terms “adapted” and “configured” should not be construed to mean that a given element, component, or other subject matter is simply “capable of” performing a given function but that the element, component, and/or other subject matter is specifically selected, created, implemented, utilized, programmed, and/or designed for the purpose of performing the function. It is also within the scope of the present disclosure that elements, components, and/or other recited subject matter that is recited as being adapted to perform a particular function may additionally or alternatively be described as being configured to perform that function, and vice versa.
As used herein, the phrase, “for example,” the phrase, “as an example,” and/or simply the term “example,” when used with reference to one or more components, features, details, structures, embodiments, and/or methods according to the present disclosure, are intended to convey that the described component, feature, detail, structure, embodiment, and/or method is an illustrative, non-exclusive example of components, features, details, structures, embodiments, and/or methods according to the present disclosure. Thus, the described component, feature, detail, structure, embodiment, and/or method is not intended to be limiting, required, or exclusive/exhaustive; and other components, features, details, structures, embodiments, and/or methods, including structurally and/or functionally similar and/or equivalent components, features, details, structures, embodiments, and/or methods, are also within the scope of the present disclosure.
Additional embodiments of the invention herein are as follows:
Embodiment 1: A method for recovering viscous hydrocarbons from a subterranean formation, the method comprising:
Embodiment 2: The method of embodiment 1, wherein the subterranean formation includes subterranean strata, which extend within the heated chamber, wherein the method further includes condensing the heated solvent vapor stream on the subterranean strata to generate condensed solvent, and further wherein the injecting the steam stream includes vaporizing the condensed solvent to generate vaporized solvent.
Embodiment 3: The method of any one of embodiments 1-2, wherein the subterranean formation includes an interface region, which extends between the heated chamber and a remainder of the subterranean formation, and further wherein the injecting the steam stream includes at least one of:
Embodiment 4: The method of any one of embodiments 1-3, wherein the injecting the steam stream includes flushing condensed solvent from the heated chamber.
Embodiment 5: The method of embodiment 4, wherein the flushing includes facilitating flow of the condensed solvent from the subterranean formation via the production well.
Embodiment 6: The method of any one of embodiments 4-5, wherein the flushing includes facilitating condensation of the heated solvent vapor stream within an/the interface region that extends between the heated chamber and a remainder of the subterranean formation.
Embodiment 7: The method of any one of embodiments 1-6, wherein the method defines an injection time ratio of the heated solvent vapor injection time period to the steam injection time period.
Embodiment 8: The method of embodiment 7, wherein, during each injection cycle of the plurality of injection cycles, the injection time ratio is one of:
Embodiment 9: The method of any one of embodiments 7-8, wherein the injection time ratio is at least 1 and one of:
Embodiment 10: The method of any one of embodiments 7-8, wherein the injection time ratio is selected to prevent fluid contact between the steam stream and an/the interface region that extends between the heated chamber and a remainder of the subterranean formation.
Embodiment 11: The method of any one of embodiments 7-10, wherein, responsive to an increase in a volume of the heated chamber, the method further includes increasing the injection time ratio in a given injection cycle of the plurality of injection cycles relative to a prior injection cycle of the plurality of injection cycles.
Embodiment 12: The method of any one of embodiments 7-11, wherein the method further includes modifying the injection time ratio for a/the given injection cycle of the plurality of injection cycles relative to a/the prior injection cycle of the plurality of injection cycles based, at least in part, on at least one of: a change in a production rate of mobilized viscous hydrocarbons;
Embodiment 13: The method of any one of embodiments 1-12, wherein the method further includes transitioning from the injecting the heated solvent vapor stream to the injecting the steam stream based, at least in part, on at least one of:
Embodiment 14: The method of any one of embodiments 1-13, wherein the heated solvent vapor injection time period is one of:
Embodiment 15: The method of any one of embodiments 1-14, wherein the heated solvent vapor injection time period is at least 1 and one of:
Embodiment 16: The method of any one of embodiments 1-15, wherein the steam injection time period is one of:
Embodiment 17: The method of any one of embodiments 1-16, wherein the steam injection time period is at least 1 and one of:
18. The method of any one of embodiments 1-17, wherein the injecting the heated solvent vapor stream includes injecting a mass of heated solvent vapor, and further wherein the injecting the steam stream includes injecting a mass of steam.
Embodiment 19: The method of embodiment 18, wherein, during each injection cycle of the plurality of injection cycles, an injection mass ratio of the mass of heated solvent vapor to the mass of steam is one of:
Embodiment 20: The method of any one of embodiments 1-19, wherein the method further includes maintaining a target operating pressure within the heated chamber.
Embodiment 21: The method of embodiment 20, wherein the maintaining includes performing the injecting the heated solvent vapor stream and the injecting the steam stream at the target operating pressure.
Embodiment 22: The method of any one of embodiments 20-21, wherein the maintaining includes selectively varying at least one of a temperature of the heated solvent vapor stream and a temperature of the steam stream to maintain the target operating pressure.
Embodiment 23: The method of any one of embodiments 1-22, wherein the fluidly contacting includes condensing the heated solvent vapor stream to form a chamber liquid that includes condensed solvent and the mobilized viscous hydrocarbons, wherein the producing includes producing at least a portion of the chamber liquid as a produced chamber liquid, and further wherein: prior to the injecting the steam stream, the method includes accumulating the chamber liquid within the heated chamber to form a chamber liquid pool within the heated chamber and immersing the at least substantially horizontal region of the injection well within the chamber liquid pool; and
Embodiment 24: The method of embodiment 23, wherein the accumulating includes accumulating such that the at least substantially horizontal region of the injection well is completely immersed within the chamber liquid pool.
Embodiment 25: The method of any one of embodiments 23-24, wherein the accumulating includes accumulating such that the at least substantially horizontal region of the injection well is a threshold distance below an upper surface of the chamber liquid pool.
Embodiment 26: The method of embodiment 25, wherein the threshold distance is at least one of:
Embodiment 27: The method of any one of embodiments 23-26, wherein the accumulating includes regulating a production rate of the produced chamber liquid to increase a volume of the chamber liquid within the heated chamber.
Embodiment 28: The method of embodiment 27, wherein the regulating includes at least one of:
Embodiment 29: The method of any one of embodiments 23-28, wherein the injecting the steam stream includes utilizing the steam stream to vaporize at least a fraction of the condensed solvent from the chamber liquid pool.
Embodiment 30: The method of any one of embodiments 23-29, wherein the method further includes monitoring a composition variable associated with a solvent content of the produced chamber liquid.
Embodiment 31: The method of embodiment 30, wherein the method further includes at least one of:
Embodiment 32: The method of any one of embodiments 30-31, wherein the monitoring the composition variable includes at least one of:
Embodiment 33: The method of any one of embodiments 23-32, wherein the method further includes monitoring a liquid level variable associated with a location of an/the upper surface of the chamber liquid pool within the heated chamber, and further wherein the accumulating is based, at least in part, on the liquid level variable.
Embodiment 34: The method of embodiment 33, wherein the monitoring the liquid level variable includes at least one of:
Embodiment 35: The method of any one of embodiments 23-34, wherein, during the injecting the steam stream, the method includes maintaining the at least substantially horizontal region of the injection well immersed within the chamber liquid pool.
Embodiment 36: The method of any one of embodiments 23-35, wherein, subsequent to the injecting the steam stream, the method further includes reducing a volume of chamber liquid within the heated chamber such that the at least substantially horizontal region of the injection well extends above an/the upper surface of the chamber liquid pool.
Embodiment 37: The method of embodiment 36, wherein, within each injection cycle of the plurality of injection cycles, the method includes performing the reducing the volume of chamber liquid within the heated chamber prior to the injecting the heated solvent vapor stream.
Embodiment 38: The method of any one of embodiments 23-37, wherein the heated solvent vapor injection time period is at least one of:
Embodiment 39: The method of any one of embodiments 23-38, wherein the method includes ceasing the injecting the steam stream responsive to a/the composition variable associated with a/the solvent content of the produced chamber liquid indicating less than a threshold solvent content in the produced chamber liquid.
Embodiment 40: The method of any one of embodiments 23-39, wherein the method includes ceasing the producing at least one of:
Embodiment 41: The method of any one of embodiments 23-40, wherein the heated solvent vapor injection time period is one of:
Embodiment 42. The method of any one of embodiments 23-41, wherein the steam injection time period is one of:
Embodiment 43: The method of any one of embodiments 1-42, wherein, subsequent to the heated solvent vapor injection time period, the method further includes ceasing the injecting the heated solvent vapor stream.
Embodiment 44: The method of any one of embodiments 1-43, wherein, prior to the steam injection time period, the method further includes ceasing the injecting the heated solvent vapor stream.
Embodiment 45: The method of any one of embodiments 1-44, wherein, subsequent to the steam injection time period, the method further includes ceasing the injecting the steam stream and resuming the injecting the heated solvent vapor stream.
Embodiment 46: The method of any one of embodiments 1-45, wherein the method further includes ceasing the injecting the steam stream during a given injection cycle of the plurality of injection cycles prior to performing the injecting the heated solvent vapor stream during a subsequent injection cycle of the plurality of injection cycles.
Embodiment 47: The method of any one of embodiments 1-46, wherein the injecting the heated solvent vapor stream includes injecting such that the heated solvent vapor stream includes at least a threshold fraction of nonaqueous species.
Embodiment 48: The method of embodiment 47, wherein the threshold fraction of nonaqueous species is one of:
Embodiment 49: The method of any one of embodiments 1-48, wherein the heated solvent vapor stream consists essentially of solvent.
Embodiment 50: The method of any one of embodiments 1-49, wherein the heated solvent vapor stream includes at least one of:
Embodiment 51: The method of any one of embodiments 1-50, wherein the heated solvent vapor stream includes at least one of water and steam.
Embodiment 52: The method of any one of embodiments 1-51, wherein the heated solvent vapor stream includes a near-azeotropic mixture of a hydrocarbon solvent and water.
Embodiment 53: The method of embodiment 52, wherein a solvent molar fraction of the hydrocarbon solvent in the near-azeotropic mixture is 70%-130% of an azeotropic solvent molar fraction of the near-azeotropic mixture at a target operating pressure within the heated chamber.
Embodiment 54: The method of any one of embodiments 1-53, wherein a bubble point temperature of the heated solvent vapor stream at a/the target operating pressure within the heated chamber is less than a bubble point temperature of the steam stream at the target operating pressure within the heated chamber.
Embodiment 55: The method of any one of embodiments 1-54, wherein the injecting the heated solvent vapor stream includes injecting as part of at least one of:
Embodiment 56: The method of any one of embodiments 1-55, wherein the injecting the steam stream includes injecting such that the steam stream includes at least a threshold fraction of steam.
Embodiment 57: The method of embodiment 56, wherein the threshold fraction of steam is one of:
Embodiment 58: The method of any one of embodiments 1-57, wherein the steam stream consists essentially of steam.
Embodiment 59: The method of any one of embodiments 1-58, wherein the producing the mobilized viscous hydrocarbons includes at least one of:
Embodiment 60: The method of any one of embodiments 1-59, wherein the producing the mobilized viscous hydrocarbons includes one of:
Embodiment 61: The method of any one of embodiments 1-60, wherein the method further includes draining the mobilized viscous hydrocarbons, under the influence of gravity, at least one of:
Embodiment 62: The method of any one of embodiments 1-61, wherein the at least substantially horizontal region of the injection well and the at least substantially horizontal region of the production well define an average separation distance therebetween.
Embodiment 63: The method of embodiment 62, wherein the average separation distance is at least one of:
Embodiment 64: The method of any one of embodiments 1-63, wherein the method further includes at least one of:
Embodiment 65: A method for recovering viscous hydrocarbons from a subterranean formation, the method comprising:
Embodiment 66: The method of embodiment 65, wherein the sequentially repeating, for a plurality of injection cycles, includes the accumulating.
Embodiment 67: The method of embodiment 65 in combination with any suitable step of any of the methods of any of claims 1-64.
The methods disclosed herein are applicable to the oil and gas industries.
It is believed that the disclosure set forth above encompasses multiple distinct inventions with independent utility. While each of these inventions has been disclosed in its preferred form, the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense as numerous variations are possible. The subject matter of the inventions includes all novel and non-obvious combinations and subcombinations of the various elements, features, functions and/or properties disclosed herein. Similarly, where the claims recite “a” or “a first” element or the equivalent thereof, such claims should be understood to include incorporation of one or more such elements, neither requiring nor excluding two or more such elements.
It is believed that the following claims particularly point out certain combinations and subcombinations that are directed to one of the disclosed inventions and are novel and non-obvious. Inventions embodied in other combinations and subcombinations of features, functions, elements and/or properties may be claimed through amendment of the present claims or presentation of new claims in this or a related application. Such amended or new claims, whether they are directed to a different invention or directed to the same invention, whether different, broader, narrower, or equal in scope to the original claims, are also regarded as included within the subject matter of the inventions of the present disclosure.
| Number | Date | Country | Kind |
|---|---|---|---|
| CA 2978157 | Aug 2017 | CA | national |
| Number | Name | Date | Kind |
|---|---|---|---|
| 1422204 | Hoover et al. | Jul 1922 | A |
| 1491138 | Hixon | Apr 1924 | A |
| 2365591 | Ranney | Dec 1944 | A |
| 2412765 | Buddrus | Dec 1946 | A |
| 2813583 | Marx et al. | Nov 1957 | A |
| 2859818 | Hall et al. | Nov 1958 | A |
| 2862558 | Dixon | Dec 1958 | A |
| 2910123 | Elkins et al. | Jan 1959 | A |
| 2876838 | Williams | Mar 1959 | A |
| 2881838 | Morse et al. | Apr 1959 | A |
| 2909224 | Allen | Oct 1959 | A |
| 3126961 | Craig, Jr. et al. | Mar 1964 | A |
| 3156299 | Trantham | Nov 1964 | A |
| 3163215 | Stratton | Dec 1964 | A |
| 3174544 | Campion et al. | Mar 1965 | A |
| 3182722 | Reed | May 1965 | A |
| 3205944 | Walton | Sep 1965 | A |
| 3221809 | Walton | Dec 1965 | A |
| 3232345 | Trantham et al. | Feb 1966 | A |
| 3237689 | Justheim | Mar 1966 | A |
| 3246693 | Crider | Apr 1966 | A |
| 3280909 | Closmann et al. | Oct 1966 | A |
| 3294167 | Vogel | Dec 1966 | A |
| 3310109 | Marx et al. | Mar 1967 | A |
| 3314476 | Staples et al. | Apr 1967 | A |
| 3315745 | Rees, Jr. | Apr 1967 | A |
| 3322194 | Strubbar | May 1967 | A |
| 3332482 | Trantham | Jul 1967 | A |
| 3333632 | Kyte | Aug 1967 | A |
| 3334687 | Parker | Aug 1967 | A |
| 3342257 | Jacobs et al. | Sep 1967 | A |
| 3342259 | Powell | Sep 1967 | A |
| 3347313 | Matthews et al. | Oct 1967 | A |
| 3349845 | Holbert et al. | Oct 1967 | A |
| 3351132 | Dougan et al. | Nov 1967 | A |
| 3361201 | Howard | Jan 1968 | A |
| 3363686 | Gilchrist | Jan 1968 | A |
| 3363687 | Dean | Jan 1968 | A |
| 3373804 | Glass et al. | Mar 1968 | A |
| 3379246 | Skylar et al. | Apr 1968 | A |
| 3379248 | Strange | Apr 1968 | A |
| 3406755 | Sharp | Oct 1968 | A |
| 3411578 | Holmes | Nov 1968 | A |
| 3412793 | Needham | Nov 1968 | A |
| 3412794 | Craighead | Nov 1968 | A |
| 3422891 | Alexander et al. | Jan 1969 | A |
| 3430700 | Satter et al. | Mar 1969 | A |
| 3441083 | Fitzgerald | Apr 1969 | A |
| 3454095 | Messenger et al. | Jul 1969 | A |
| 3454958 | Parker | Jul 1969 | A |
| 3456721 | Smith | Jul 1969 | A |
| 3490529 | Parker | Jan 1970 | A |
| 3490531 | Dixon | Jan 1970 | A |
| 3507330 | Gill | Apr 1970 | A |
| 3547192 | Claridge et al. | Dec 1970 | A |
| 3554285 | Meldau | Jan 1971 | A |
| 3572436 | Riehl | Mar 1971 | A |
| 3605888 | Crowson et al. | Sep 1971 | A |
| 3608638 | Terwiltiger | Sep 1971 | A |
| 3653438 | Wagner | Apr 1972 | A |
| 3685581 | Hess et al. | Aug 1972 | A |
| 3690376 | Zwicky et al. | Sep 1972 | A |
| 3703927 | Harry | Nov 1972 | A |
| 3705625 | Whitten et al. | Dec 1972 | A |
| 3724043 | Eustance | Apr 1973 | A |
| 3727686 | Prates et al. | Apr 1973 | A |
| 3759328 | Ueber et al. | Sep 1973 | A |
| 3768559 | Allen et al. | Oct 1973 | A |
| 3771598 | McBean | Nov 1973 | A |
| 3782465 | Bell et al. | Jan 1974 | A |
| 3782472 | Siess, Jr. | Jan 1974 | A |
| 3796262 | Allen et al. | Mar 1974 | A |
| 3804169 | Closmann | Apr 1974 | A |
| 3805885 | Van Huisen | Apr 1974 | A |
| 3822747 | Maguire, Jr. | Jul 1974 | A |
| 3822748 | Allen et al. | Jul 1974 | A |
| 3823777 | Allen et al. | Jul 1974 | A |
| 3827495 | Reed | Aug 1974 | A |
| 3837399 | Allen et al. | Sep 1974 | A |
| 3837402 | Stringer | Sep 1974 | A |
| 3838738 | Redford et al. | Oct 1974 | A |
| 3847219 | Wang et al. | Nov 1974 | A |
| 3847224 | Allen et al. | Nov 1974 | A |
| 3872924 | Clampitt | Mar 1975 | A |
| 3881550 | Barry | May 1975 | A |
| 3882941 | Pelofsky | May 1975 | A |
| 3892270 | Lindquist | Jul 1975 | A |
| 3905422 | Woodward | Sep 1975 | A |
| 3913671 | Redford et al. | Oct 1975 | A |
| 3929190 | Chang et al. | Dec 1975 | A |
| 3931856 | Barnes | Jan 1976 | A |
| 3941192 | Carlin et al. | Mar 1976 | A |
| 3945436 | Barry | Mar 1976 | A |
| 3945679 | Clossmann et al. | Mar 1976 | A |
| 3946809 | Hagedorn | Mar 1976 | A |
| 3946810 | Barry | Mar 1976 | A |
| 3954139 | Allen | May 1976 | A |
| 3954141 | Allen et al. | May 1976 | A |
| 3958636 | Perkins | May 1976 | A |
| 3964546 | Allen | Jun 1976 | A |
| 3964547 | Hujsak et al. | Jun 1976 | A |
| 3967853 | Closmann et al. | Jul 1976 | A |
| 3978920 | Bandyopadhyay et al. | Sep 1976 | A |
| 3983939 | Brown et al. | Oct 1976 | A |
| 3993133 | Clampitt | Nov 1976 | A |
| 3994341 | Anderson et al. | Nov 1976 | A |
| 3997004 | Wu | Dec 1976 | A |
| 3999606 | Bandyopadhyay et al. | Dec 1976 | A |
| 4003432 | Paull et al. | Jan 1977 | A |
| 4004636 | Brown et al. | Jan 1977 | A |
| 4007785 | Allen et al. | Feb 1977 | A |
| 4007791 | Johnson | Feb 1977 | A |
| 4008764 | Allen | Feb 1977 | A |
| 4008765 | Anderson et al. | Feb 1977 | A |
| 4019575 | Pisio et al. | Apr 1977 | A |
| 4019578 | Terry et al. | Apr 1977 | A |
| 4020901 | Pisio et al. | May 1977 | A |
| 4022275 | Brandon | May 1977 | A |
| 4022277 | Routson | May 1977 | A |
| 4022279 | Driver | May 1977 | A |
| 4022280 | Stoddard et al. | May 1977 | A |
| 4026358 | Allen | May 1977 | A |
| 4033411 | Goins | Jul 1977 | A |
| 4037655 | Carpenter | Jul 1977 | A |
| 4037658 | Anderson | Jul 1977 | A |
| 4049053 | Fisher et al. | Sep 1977 | A |
| 4066127 | Harnsberger | Jan 1978 | A |
| 4067391 | Dewell | Jan 1978 | A |
| 4068715 | Wu | Jan 1978 | A |
| 4068717 | Needham | Jan 1978 | A |
| 4078608 | Allen et al. | Mar 1978 | A |
| 4079585 | Helleur | Mar 1978 | A |
| 4084637 | Todd | Apr 1978 | A |
| 4085799 | Bousaid et al. | Apr 1978 | A |
| 4085800 | Engle et al. | Apr 1978 | A |
| 4085803 | Butler | Apr 1978 | A |
| 4088188 | Widmyer | May 1978 | A |
| 4099564 | Hutchinson | Jul 1978 | A |
| 4099568 | Allen | Jul 1978 | A |
| 4109720 | Allen et al. | Aug 1978 | A |
| 4114687 | Payton | Sep 1978 | A |
| 4114691 | Payton | Sep 1978 | A |
| 4116275 | Butler et al. | Sep 1978 | A |
| 4119149 | Wu et al. | Oct 1978 | A |
| 4120357 | Anderson | Oct 1978 | A |
| 4124071 | Allen et al. | Nov 1978 | A |
| 4124074 | Allen et al. | Nov 1978 | A |
| 4127170 | Redford | Nov 1978 | A |
| 4129183 | Kalfoglou | Dec 1978 | A |
| 4129308 | Hutchinson | Dec 1978 | A |
| 4130163 | Bombardieri | Dec 1978 | A |
| 4133382 | Cram et al. | Jan 1979 | A |
| 4133384 | Allen et al. | Jan 1979 | A |
| 4140180 | Bridges et al. | Feb 1979 | A |
| 4140182 | Vriend | Feb 1979 | A |
| 4141415 | Wu et al. | Feb 1979 | A |
| 4144935 | Bridges et al. | Mar 1979 | A |
| RE30019 | Lindquist | Jun 1979 | E |
| 4160479 | Richardson et al. | Jul 1979 | A |
| 4160481 | Turk et al. | Jul 1979 | A |
| 4166503 | Hall et al. | Sep 1979 | A |
| 4174752 | Slater et al. | Nov 1979 | A |
| 4175618 | Wu et al. | Nov 1979 | A |
| 4191252 | Buckley et al. | Mar 1980 | A |
| 4202168 | Acheson et al. | May 1980 | A |
| 4202169 | Acheson et al. | May 1980 | A |
| 4207945 | Hall et al. | Jun 1980 | A |
| 4212353 | Hall | Jul 1980 | A |
| 4217956 | Goss et al. | Aug 1980 | A |
| 4223728 | Pegg | Sep 1980 | A |
| 4228853 | Harvey et al. | Oct 1980 | A |
| 4228854 | Sacuta | Oct 1980 | A |
| 4228856 | Reale | Oct 1980 | A |
| 4246966 | Stoddard et al. | Jan 1981 | A |
| 4248302 | Churchman | Feb 1981 | A |
| 4249602 | Burton, III et al. | Feb 1981 | A |
| 4250964 | Jewell et al. | Feb 1981 | A |
| 4252194 | Felber et al. | Feb 1981 | A |
| 4260018 | Shum et al. | Apr 1981 | A |
| 4262745 | Stewart | Apr 1981 | A |
| 4265310 | Britton et al. | May 1981 | A |
| 4270609 | Choules | Jun 1981 | A |
| 4271905 | Redford et al. | Jun 1981 | A |
| 4274487 | Hollingsworth et al. | Jun 1981 | A |
| 4280559 | Best | Jul 1981 | A |
| 4282929 | Krajicek | Aug 1981 | A |
| 4284139 | Sweany | Aug 1981 | A |
| RE30738 | Bridges et al. | Sep 1981 | E |
| 4289203 | Swanson | Sep 1981 | A |
| 4295980 | Motz | Oct 1981 | A |
| 4296814 | Stalder et al. | Oct 1981 | A |
| 4300634 | Clampitt | Nov 1981 | A |
| 4303126 | Blevins | Dec 1981 | A |
| 4305463 | Zakiewicz | Dec 1981 | A |
| 4306981 | Blair, Jr. | Dec 1981 | A |
| 4319632 | Marr, Jr. | Mar 1982 | A |
| 4319635 | Jones | Mar 1982 | A |
| 4324291 | Wong et al. | Apr 1982 | A |
| 4325432 | Henry | Apr 1982 | A |
| 4326968 | Blair, Jr. | Apr 1982 | A |
| 4327805 | Poston | May 1982 | A |
| 4330038 | Soukup et al. | May 1982 | A |
| 4333529 | McCorquodale | Jun 1982 | A |
| 4344483 | Fisher et al. | Aug 1982 | A |
| 4344485 | Butler | Aug 1982 | A |
| 4344486 | Parrish | Aug 1982 | A |
| 4345652 | Roque | Aug 1982 | A |
| 4362213 | Tabor | Dec 1982 | A |
| 4372385 | Rhoades et al. | Feb 1983 | A |
| 4372386 | Rhoades et al. | Feb 1983 | A |
| 4379489 | Rollmann | Apr 1983 | A |
| 4379592 | Vakhnin et al. | Apr 1983 | A |
| 4380265 | Mohaupt | Apr 1983 | A |
| 4380267 | Fox | Apr 1983 | A |
| 4381124 | Verty et al. | Apr 1983 | A |
| 4382469 | Bell et al. | May 1983 | A |
| 4385661 | Fox | May 1983 | A |
| 4387016 | Gagon | Jun 1983 | A |
| 4389320 | Clampitt | Jun 1983 | A |
| 4390062 | Fox | Jun 1983 | A |
| 4390067 | William | Jun 1983 | A |
| 4392530 | Odeh et al. | Jul 1983 | A |
| 4393937 | Dilgren et al. | Jul 1983 | A |
| 4396063 | Godbey | Aug 1983 | A |
| 4398602 | Anderson | Aug 1983 | A |
| 4398692 | Macfie | Aug 1983 | A |
| 4406499 | Yildirim | Sep 1983 | A |
| 4407367 | Kydd | Oct 1983 | A |
| 4410216 | Allen | Oct 1983 | A |
| 4411618 | Donaldson et al. | Oct 1983 | A |
| 4412585 | Bouck | Nov 1983 | A |
| 4415034 | Bouck | Nov 1983 | A |
| 4417620 | Shafir | Nov 1983 | A |
| 4418752 | Boyer et al. | Dec 1983 | A |
| 4423779 | Livingston | Jan 1984 | A |
| 4427528 | Lindörfer et al. | Jan 1984 | A |
| 4429744 | Cook | Feb 1984 | A |
| 4429745 | Cook | Feb 1984 | A |
| 4431056 | Shu | Feb 1984 | A |
| 4434851 | Haynes, Jr. et al. | Mar 1984 | A |
| 4441555 | Shu | Apr 1984 | A |
| 4444257 | Stine | Apr 1984 | A |
| 4444261 | Islip | Apr 1984 | A |
| 4445573 | McCaleb | May 1984 | A |
| 4448251 | Stine | May 1984 | A |
| 4450909 | Sacuta | May 1984 | A |
| 4450911 | Seglin et al. | May 1984 | A |
| 4450913 | Allen et al. | May 1984 | A |
| 4452491 | Seglin et al. | Jun 1984 | A |
| 4453597 | Brown et al. | Jun 1984 | A |
| 4456065 | Heim et al. | Jun 1984 | A |
| 4456066 | Shu | Jun 1984 | A |
| 4456068 | Burrill, Jr. et al. | Jun 1984 | A |
| 4458756 | Clark | Jul 1984 | A |
| 4458759 | Isaacs et al. | Jul 1984 | A |
| 4460044 | Porter | Jul 1984 | A |
| 4465137 | Sustek, Jr. et al. | Aug 1984 | A |
| 4466485 | Shu | Aug 1984 | A |
| 4469177 | Venkatesan | Sep 1984 | A |
| 4471839 | Snavely et al. | Sep 1984 | A |
| 4473114 | Bell et al. | Sep 1984 | A |
| 4475592 | Pachovsky | Oct 1984 | A |
| 4475595 | Watkins et al. | Oct 1984 | A |
| 4478280 | Hopkins et al. | Oct 1984 | A |
| 4478705 | Ganguli | Oct 1984 | A |
| 4480689 | Wunderlich | Nov 1984 | A |
| 4484630 | Chung | Nov 1984 | A |
| 4485868 | Sresty et al. | Dec 1984 | A |
| 4487262 | Venkatesan et al. | Dec 1984 | A |
| 4487264 | Hyne et al. | Dec 1984 | A |
| 4488600 | Fan | Dec 1984 | A |
| 4488976 | Dilgren et al. | Dec 1984 | A |
| 4491180 | Brown et al. | Jan 1985 | A |
| 4495994 | Brown et al. | Jan 1985 | A |
| 4498537 | Cook | Feb 1985 | A |
| 4498542 | Eisenhawer et al. | Feb 1985 | A |
| 4499946 | Martin et al. | Feb 1985 | A |
| 4501325 | Frazier et al. | Feb 1985 | A |
| 4501326 | Edmunds | Feb 1985 | A |
| 4501445 | Gregoli | Feb 1985 | A |
| 4503910 | Shu | Mar 1985 | A |
| 4503911 | Harman et al. | Mar 1985 | A |
| 4508170 | Littmann | Apr 1985 | A |
| 4513819 | Islip et al. | Apr 1985 | A |
| 4515215 | Hermes et al. | May 1985 | A |
| 4516636 | Doscher | May 1985 | A |
| 4522260 | Wolcott, Jr. | Jun 1985 | A |
| 4522263 | Hopkins et al. | Jun 1985 | A |
| 4524826 | Savage | Jun 1985 | A |
| 4527650 | Bartholet | Jul 1985 | A |
| 4528104 | House et al. | Jul 1985 | A |
| 4530401 | Hartman et al. | Jul 1985 | A |
| 4532993 | Dilgren et al. | Aug 1985 | A |
| 4532994 | Toma et al. | Aug 1985 | A |
| 4535845 | Brown et al. | Aug 1985 | A |
| 4540049 | Hawkins et al. | Sep 1985 | A |
| 4540050 | Huang et al. | Sep 1985 | A |
| 4545435 | Bridges et al. | Oct 1985 | A |
| 4546829 | Martin et al. | Oct 1985 | A |
| 4550779 | Zakiewicz | Nov 1985 | A |
| 4556107 | Duerksen et al. | Dec 1985 | A |
| 4558740 | Yellig, Jr. | Dec 1985 | A |
| 4565245 | Mims et al. | Jan 1986 | A |
| 4565249 | Pebdani et al. | Jan 1986 | A |
| 4572296 | Watkins | Feb 1986 | A |
| 4574884 | Schmidt | Mar 1986 | A |
| 4574886 | Hopkins et al. | Mar 1986 | A |
| 4577688 | Gassmann et al. | Mar 1986 | A |
| 4579176 | Davies et al. | Apr 1986 | A |
| 4589487 | Venkatesan et al. | May 1986 | A |
| 4595057 | Deming et al. | Jun 1986 | A |
| 4597441 | Ware et al. | Jul 1986 | A |
| 4597443 | Shu et al. | Jul 1986 | A |
| 4598770 | Shu et al. | Jul 1986 | A |
| 4601337 | Lau et al. | Jul 1986 | A |
| 4601338 | Prats et al. | Jul 1986 | A |
| 4607695 | Weber | Aug 1986 | A |
| 4607699 | Stephens | Aug 1986 | A |
| 4607700 | Duerksen et al. | Aug 1986 | A |
| 4610304 | Doscher | Sep 1986 | A |
| 4612989 | Rakach et al. | Sep 1986 | A |
| 4612990 | Shu | Sep 1986 | A |
| 4615391 | Garthoffner | Oct 1986 | A |
| 4620592 | Perkins | Nov 1986 | A |
| 4620593 | Haagensen | Nov 1986 | A |
| 4635720 | Chew | Jan 1987 | A |
| 4637461 | Hight | Jan 1987 | A |
| 4637466 | Hawkins et al. | Jan 1987 | A |
| 4640352 | Vanmeurs et al. | Feb 1987 | A |
| 4640359 | Livesey et al. | Feb 1987 | A |
| 4641710 | Klinger | Feb 1987 | A |
| 4645003 | Huang et al. | Feb 1987 | A |
| 4645004 | Bridges et al. | Feb 1987 | A |
| 4646824 | Huang et al. | Mar 1987 | A |
| 4648835 | Esienhawer et al. | Mar 1987 | A |
| 4651825 | Wilson | Mar 1987 | A |
| 4651826 | Holmes | Mar 1987 | A |
| 4653583 | Huang et al. | Mar 1987 | A |
| 4662438 | Taflove et al. | May 1987 | A |
| 4662440 | Harmon et al. | May 1987 | A |
| 4662441 | Huang et al. | May 1987 | A |
| 4665035 | Tunac | May 1987 | A |
| 4665989 | Wilson | May 1987 | A |
| 4667739 | Van Meurs et al. | May 1987 | A |
| 4679626 | Perkins | Jul 1987 | A |
| 4682652 | Huang et al. | Jul 1987 | A |
| 4682653 | Angstadt | Jul 1987 | A |
| 4685515 | Huang et al. | Aug 1987 | A |
| 4687058 | Casad et al. | Aug 1987 | A |
| 4690215 | Roberts et al. | Sep 1987 | A |
| 4691773 | Ward et al. | Sep 1987 | A |
| 4694907 | Stahl et al. | Sep 1987 | A |
| 4696311 | Muiis et al. | Sep 1987 | A |
| 4697642 | Vogel | Oct 1987 | A |
| 4699213 | Fleming | Oct 1987 | A |
| 4700779 | Huang et al. | Oct 1987 | A |
| 4702314 | Huang et al. | Oct 1987 | A |
| 4702317 | Shen | Oct 1987 | A |
| 4705108 | Little et al. | Nov 1987 | A |
| 4706751 | Gondouin | Nov 1987 | A |
| 4707230 | Ajami | Nov 1987 | A |
| 4718485 | Brown et al. | Jan 1988 | A |
| 4718489 | Hallam et al. | Jan 1988 | A |
| 4727489 | Frazier et al. | Feb 1988 | A |
| 4727937 | Shum et al. | Mar 1988 | A |
| 4739831 | Settlemeyer et al. | Apr 1988 | A |
| 4753293 | Bohn | Jun 1988 | A |
| 4756369 | Jennings, Jr. et al. | Jul 1988 | A |
| 4757833 | Danley | Jul 1988 | A |
| 4759571 | Stone et al. | Jul 1988 | A |
| 4766958 | Faecke | Aug 1988 | A |
| 4769161 | Angstadt | Sep 1988 | A |
| 4775450 | Ajami | Oct 1988 | A |
| 4782901 | Phelps et al. | Nov 1988 | A |
| 4785028 | Hoskin et al. | Nov 1988 | A |
| 4785883 | Hoskin et al. | Nov 1988 | A |
| 4787452 | Jennings, Jr. | Nov 1988 | A |
| 4793409 | Bridges et al. | Dec 1988 | A |
| 4793415 | Holmes et al. | Dec 1988 | A |
| 4804043 | Shu et al. | Feb 1989 | A |
| 4809780 | Shen | Mar 1989 | A |
| 4813483 | Ziegler | Mar 1989 | A |
| 4817711 | Jeambey | Apr 1989 | A |
| 4817714 | Jones | Apr 1989 | A |
| 4818370 | Gregoli et al. | Apr 1989 | A |
| 4819724 | Bou-Mikael | Apr 1989 | A |
| 4828030 | Jennings, Jr. | May 1989 | A |
| 4828031 | Davis | May 1989 | A |
| 4828032 | Telezke et al. | May 1989 | A |
| 4834174 | Vandevier | May 1989 | A |
| 4834179 | Kokolis et al. | May 1989 | A |
| 4844155 | Megyeri et al. | Jul 1989 | A |
| 4846275 | McKay | Jul 1989 | A |
| 4850429 | Mims et al. | Jul 1989 | A |
| 4856587 | Nielson | Aug 1989 | A |
| 4856856 | Phelps et al. | Aug 1989 | A |
| 4860827 | Lee et al. | Aug 1989 | A |
| 4861263 | Schirmer | Aug 1989 | A |
| 4867238 | Bayless et al. | Sep 1989 | A |
| 4869830 | Konak et al. | Sep 1989 | A |
| 4874043 | Joseph et al. | Oct 1989 | A |
| 4877542 | Lon et al. | Oct 1989 | A |
| 4884155 | Spash | Nov 1989 | A |
| 4884635 | McKay et al. | Dec 1989 | A |
| 4886118 | Van Meurs et al. | Dec 1989 | A |
| 4892146 | Shen | Jan 1990 | A |
| 4895085 | Chips | Jan 1990 | A |
| 4895206 | Price | Jan 1990 | A |
| 4896725 | Parker et al. | Jan 1990 | A |
| 4901795 | Phelps et al. | Feb 1990 | A |
| 4903766 | Shu | Feb 1990 | A |
| 4903768 | Shu | Feb 1990 | A |
| 4903770 | Friedeman et al. | Feb 1990 | A |
| 4915170 | Hoskin | Apr 1990 | A |
| 4919206 | Freeman et al. | Apr 1990 | A |
| 4926941 | Glandt et al. | May 1990 | A |
| 4926943 | Hoskin | May 1990 | A |
| 4928766 | Hoskin | May 1990 | A |
| 4930454 | Latty et al. | Jun 1990 | A |
| 4940091 | Shu et al. | Jul 1990 | A |
| 4945984 | Price | Aug 1990 | A |
| 4947933 | Jones et al. | Aug 1990 | A |
| 4961467 | Pebdani | Oct 1990 | A |
| 4962814 | Alameddine | Oct 1990 | A |
| 4964461 | Shu | Oct 1990 | A |
| 4966235 | Gregoli et al. | Oct 1990 | A |
| 4969520 | Jan et al. | Nov 1990 | A |
| 4974677 | Shu | Dec 1990 | A |
| 4982786 | Jennings, Jr. | Jan 1991 | A |
| 4983364 | Buck et al. | Jan 1991 | A |
| 4991652 | Hoskin et al. | Feb 1991 | A |
| 5010953 | Friedman et al. | Apr 1991 | A |
| 5013462 | Danley | May 1991 | A |
| 5014787 | Duerksen | May 1991 | A |
| 5016709 | Combe et al. | May 1991 | A |
| 5016710 | Renard et al. | May 1991 | A |
| 5016713 | Sanchez et al. | May 1991 | A |
| 5024275 | Anderson et al. | Jun 1991 | A |
| 5025863 | Haines | Jun 1991 | A |
| 5027898 | Naae | Jul 1991 | A |
| 5036915 | Wyganowski | Aug 1991 | A |
| 5036917 | Jennings, Jr. et al. | Aug 1991 | A |
| 5036918 | Jennings, Jr. et al. | Aug 1991 | A |
| 5040605 | Showalter | Aug 1991 | A |
| 5042579 | Glandt et al. | Aug 1991 | A |
| 5046559 | Glandt | Sep 1991 | A |
| 5046560 | Teletzke et al. | Sep 1991 | A |
| 5052482 | Gondouin | Oct 1991 | A |
| 5054551 | Duerksen | Oct 1991 | A |
| 5056596 | McKay et al. | Oct 1991 | A |
| 5058681 | Reed | Oct 1991 | A |
| 5060726 | Glandt et al. | Oct 1991 | A |
| 5065819 | Kasevich | Nov 1991 | A |
| 5083612 | Ashrawi | Jan 1992 | A |
| 5083613 | Gregoli et al. | Jan 1992 | A |
| 5085275 | Gondouin | Feb 1992 | A |
| 5095984 | Irani | Mar 1992 | A |
| 5099918 | Bridges et al. | Mar 1992 | A |
| 5101898 | Hong | Apr 1992 | A |
| 5105880 | Shen | Apr 1992 | A |
| 5109927 | Supernaw et al. | May 1992 | A |
| 5123485 | Vasicek et al. | Jun 1992 | A |
| 5131471 | Duerksen et al. | Jul 1992 | A |
| 5145002 | McKay | Sep 1992 | A |
| 5145003 | Duerksen | Sep 1992 | A |
| 5148869 | Sanchez | Sep 1992 | A |
| 5152341 | Kasevich et al. | Oct 1992 | A |
| 5156214 | Hoskin et al. | Oct 1992 | A |
| 5167280 | Sanchez et al. | Dec 1992 | A |
| 5172763 | Mohammadi et al. | Dec 1992 | A |
| 5174377 | Kumar | Dec 1992 | A |
| 5178217 | Mohammadi et al. | Jan 1993 | A |
| 5186256 | Downs | Feb 1993 | A |
| 5197541 | Hess et al. | Mar 1993 | A |
| 5199488 | Kasevich et al. | Apr 1993 | A |
| 5199490 | Surles et al. | Apr 1993 | A |
| 5201815 | Hong et al. | Apr 1993 | A |
| 5215146 | Sanchez | Jun 1993 | A |
| 5215149 | Lu | Jun 1993 | A |
| 5236039 | Edelstein et al. | Aug 1993 | A |
| 5238066 | Beattie et al. | Aug 1993 | A |
| 5246071 | Chu | Sep 1993 | A |
| 5247993 | Sarem et al. | Sep 1993 | A |
| 5252226 | Justice | Oct 1993 | A |
| 5271693 | Johnson et al. | Dec 1993 | A |
| 5273111 | Brannan et al. | Dec 1993 | A |
| 5277830 | Hoskin et al. | Jan 1994 | A |
| 5279367 | Osterloh | Jan 1994 | A |
| 5282508 | Ellingsen et al. | Feb 1994 | A |
| 5289881 | Schuh | Mar 1994 | A |
| 5293936 | Bridges | Mar 1994 | A |
| 5295540 | Djabbarah et al. | Mar 1994 | A |
| 5297627 | Sanchez et al. | Mar 1994 | A |
| 5305829 | Kumar | Apr 1994 | A |
| 5318124 | Ong et al. | Jun 1994 | A |
| 5325918 | Berryman et al. | Jul 1994 | A |
| 5339897 | Leaute | Aug 1994 | A |
| 5339898 | Yu et al. | Aug 1994 | A |
| 5339904 | Jennings, Jr. et al. | Aug 1994 | A |
| 5350014 | McKay | Sep 1994 | A |
| 5358054 | Bert | Oct 1994 | A |
| 5361845 | Jamaluddin et al. | Nov 1994 | A |
| 5377757 | Ng | Jan 1995 | A |
| 5404950 | Ng et al. | Apr 1995 | A |
| 5407009 | Butler et al. | Apr 1995 | A |
| 5411086 | Burcham et al. | May 1995 | A |
| 5411089 | Vinegar et al. | May 1995 | A |
| 5411094 | Northrop | May 1995 | A |
| 5413175 | Edmunds | May 1995 | A |
| 5414231 | Sato et al. | May 1995 | A |
| 5417283 | Ejiogu et al. | May 1995 | A |
| 5431224 | Laali | Jul 1995 | A |
| 5433271 | Vinegar et al. | Jul 1995 | A |
| 5449038 | Horton et al. | Sep 1995 | A |
| 5450902 | Mathews | Sep 1995 | A |
| 5456315 | Kinsman et al. | Oct 1995 | A |
| 5458193 | Horton et al. | Oct 1995 | A |
| 5483801 | Craze | Jan 1996 | A |
| 5503226 | Wadleigh | Apr 1996 | A |
| 5511616 | Bert | Apr 1996 | A |
| 5513705 | Djabbarah et al. | May 1996 | A |
| 5531272 | Ng et al. | Jul 1996 | A |
| 5534186 | Walker et al. | Jul 1996 | A |
| 5542474 | Djabbarah et al. | Aug 1996 | A |
| 5547022 | Juprasert et al. | Aug 1996 | A |
| 5553974 | Nazarian | Sep 1996 | A |
| 5560737 | Schuring et al. | Oct 1996 | A |
| 5565139 | Walker et al. | Oct 1996 | A |
| 5589775 | Kuckes | Dec 1996 | A |
| 5607016 | Butler | Mar 1997 | A |
| 5607018 | Schuh | Mar 1997 | A |
| 5626191 | Greaves et al. | May 1997 | A |
| 5626193 | Nzekwu et al. | May 1997 | A |
| 5635139 | Holst et al. | Jun 1997 | A |
| 5646309 | Hammarberg et al. | Jul 1997 | A |
| 5650128 | Holst et al. | Jul 1997 | A |
| 5660500 | Marsden, Jr. et al. | Aug 1997 | A |
| 5674816 | Loree | Oct 1997 | A |
| 5677267 | Suarez et al. | Oct 1997 | A |
| 5682613 | Dinatale | Nov 1997 | A |
| 5685371 | Richardson et al. | Nov 1997 | A |
| 5691906 | Togashi et al. | Nov 1997 | A |
| 5709505 | Williams et al. | Jan 1998 | A |
| 5713415 | Bridges | Feb 1998 | A |
| 5720350 | McGuire | Feb 1998 | A |
| 5725054 | Shayegi | Mar 1998 | A |
| 5738937 | Baychar | Apr 1998 | A |
| 5765964 | Calcote et al. | Jun 1998 | A |
| 5771973 | Jensen | Jun 1998 | A |
| 5788412 | Jatkar | Aug 1998 | A |
| RE35891 | Jamaluddin et al. | Sep 1998 | E |
| 5803171 | McCaffery et al. | Sep 1998 | A |
| 5803178 | Cain | Sep 1998 | A |
| 5813799 | Calcote et al. | Sep 1998 | A |
| 5823631 | Herbolzheimer et al. | Oct 1998 | A |
| 5826656 | McGuire et al. | Oct 1998 | A |
| 5860475 | Ejiogu et al. | Jan 1999 | A |
| 5899274 | Frauenfeld et al. | May 1999 | A |
| 5923170 | Kuckes | Jul 1999 | A |
| 5931230 | Lesage et al. | Aug 1999 | A |
| 5941081 | Burgener | Aug 1999 | A |
| 5957202 | Huang | Sep 1999 | A |
| 5984010 | Elias et al. | Nov 1999 | A |
| 6000471 | Langset | Dec 1999 | A |
| 6004451 | Rock et al. | Dec 1999 | A |
| 6012520 | Yu et al. | Jan 2000 | A |
| 6015015 | Luft et al. | Jan 2000 | A |
| 6016867 | Gregoli et al. | Jan 2000 | A |
| 6016868 | Gregoli et al. | Jan 2000 | A |
| 6026914 | Adams et al. | Feb 2000 | A |
| 6039116 | Stevenson et al. | Mar 2000 | A |
| 6039121 | Kisman | Mar 2000 | A |
| 6048810 | Baychar | Apr 2000 | A |
| 6050335 | Parsons | Apr 2000 | A |
| 6056057 | Vinegar et al. | May 2000 | A |
| 6102122 | de Rouffignac | Aug 2000 | A |
| 6109358 | McPhee et al. | Aug 2000 | A |
| 6148911 | Gipson et al. | Nov 2000 | A |
| 6158510 | Bacon et al. | Dec 2000 | A |
| 6158513 | Nistor et al. | Dec 2000 | A |
| 6167966 | Ayasse et al. | Jan 2001 | B1 |
| 6173775 | Elias et al. | Jan 2001 | B1 |
| 6186232 | Isaccs et al. | Feb 2001 | B1 |
| 6189611 | Kasevich | Feb 2001 | B1 |
| 6205289 | Kobro | Mar 2001 | B1 |
| 6230814 | Nasr et al. | May 2001 | B1 |
| 6244341 | Miller | Jun 2001 | B1 |
| 6257334 | Cyr et al. | Jul 2001 | B1 |
| 6263965 | Schmidt et al. | Jul 2001 | B1 |
| 6276457 | Moffatt et al. | Aug 2001 | B1 |
| 6285014 | Beck et al. | Sep 2001 | B1 |
| 6305472 | Richardson et al. | Oct 2001 | B2 |
| 6318464 | Mokrys | Nov 2001 | B1 |
| 6325147 | Doerler et al. | Dec 2001 | B1 |
| 6328104 | Graue | Dec 2001 | B1 |
| 6353706 | Bridges | Mar 2002 | B1 |
| 6357526 | Abdel-Halim et al. | Mar 2002 | B1 |
| 6405799 | Vallejos et al. | Jun 2002 | B1 |
| 6409226 | Slack et al. | Jun 2002 | B1 |
| 6412557 | Ayasse et al. | Jul 2002 | B1 |
| 6413016 | Nelson et al. | Jul 2002 | B1 |
| 6454010 | Thomas et al. | Sep 2002 | B1 |
| 6484805 | Perkins et al. | Nov 2002 | B1 |
| 6536523 | Kresnyak et al. | Mar 2003 | B1 |
| 6554067 | Davies et al. | Apr 2003 | B1 |
| 6561274 | Hayes et al. | May 2003 | B1 |
| 6581684 | Wellington et al. | Jun 2003 | B2 |
| 6588500 | Lewis | Jul 2003 | B2 |
| 6591908 | Nasr | Jul 2003 | B2 |
| 6607036 | Ranson et al. | Aug 2003 | B2 |
| 6631761 | Yuan et al. | Oct 2003 | B2 |
| 6662872 | Gutek et al. | Dec 2003 | B2 |
| 6666666 | Gilbert et al. | Dec 2003 | B1 |
| 6681859 | Hill | Jan 2004 | B2 |
| 6688387 | Wellington et al. | Feb 2004 | B1 |
| 6702016 | de Rouffignac et al. | Mar 2004 | B2 |
| 6708759 | Leaute | Mar 2004 | B2 |
| 6712136 | de Rouffignac et al. | Mar 2004 | B2 |
| 6712150 | Misselbrook et al. | Mar 2004 | B1 |
| 6715546 | Vinegar et al. | Apr 2004 | B2 |
| 6715547 | Vinegar et al. | Apr 2004 | B2 |
| 6715548 | Wellington et al. | Apr 2004 | B2 |
| 6715549 | Wellington et al. | Apr 2004 | B2 |
| 6719047 | Fowler et al. | Apr 2004 | B2 |
| 6722429 | de Rouffignac et al. | Apr 2004 | B2 |
| 6722431 | Karanikas et al. | Apr 2004 | B2 |
| 6725920 | Zhang et al. | Apr 2004 | B2 |
| 6729394 | Hassan et al. | May 2004 | B1 |
| 6729395 | Shahin, Jr. et al. | May 2004 | B2 |
| 6729397 | Zhang et al. | May 2004 | B2 |
| 6729401 | Vinegar et al. | May 2004 | B2 |
| 6732794 | Wellington et al. | May 2004 | B2 |
| 6732795 | de Rouffignac et al. | May 2004 | B2 |
| 6732796 | Vinegar et al. | May 2004 | B2 |
| 6733636 | Heins | May 2004 | B1 |
| 6736215 | Maher et al. | May 2004 | B2 |
| 6736222 | Kuckes et al. | May 2004 | B2 |
| 6739394 | Vinegar et al. | May 2004 | B2 |
| 6742588 | Wellington et al. | Jun 2004 | B2 |
| 6742593 | Vinegar et al. | Jun 2004 | B2 |
| 6745831 | de Rouffignac et al. | Jun 2004 | B2 |
| 6745832 | Wellington et al. | Jun 2004 | B2 |
| 6745837 | Wellington et al. | Jun 2004 | B2 |
| 6755246 | Chen et al. | Jun 2004 | B2 |
| 6758268 | Vinegar et al. | Jul 2004 | B2 |
| 6769486 | Lim et al. | Aug 2004 | B2 |
| 6782947 | de Rouffignac et al. | Aug 2004 | B2 |
| 6789625 | de Rouffignac et al. | Sep 2004 | B2 |
| 6794864 | Mirotchnik et al. | Sep 2004 | B2 |
| 6805195 | Vinegar et al. | Oct 2004 | B2 |
| 6814141 | Huh et al. | Nov 2004 | B2 |
| 6877556 | Wittle et al. | Apr 2005 | B2 |
| 6883607 | Nenniger et al. | Apr 2005 | B2 |
| 6962466 | Vinegar et al. | Nov 2005 | B2 |
| 7013970 | Collie et al. | Mar 2006 | B2 |
| 7056725 | Lu | Jun 2006 | B1 |
| 7069990 | Bilak | Jul 2006 | B1 |
| 7272973 | Craig | Sep 2007 | B2 |
| 7294156 | Chakrabarty et al. | Nov 2007 | B2 |
| 7322409 | Wittle et al. | Jan 2008 | B2 |
| 7363973 | Nenniger et al. | Apr 2008 | B2 |
| 7434619 | Rossi et al. | Oct 2008 | B2 |
| 7464756 | Gates et al. | Dec 2008 | B2 |
| 7527096 | Chung et al. | May 2009 | B2 |
| 7770643 | Daussin | Aug 2010 | B2 |
| 7918269 | Cavender et al. | Apr 2011 | B2 |
| 7975763 | Banerjee et al. | Jul 2011 | B2 |
| 8141636 | Speirs et al. | Mar 2012 | B2 |
| 8176982 | Gil et al. | May 2012 | B2 |
| 8215392 | Rao | Jul 2012 | B2 |
| 8256511 | Boone et al. | Sep 2012 | B2 |
| 8327936 | Coskuner | Dec 2012 | B2 |
| 8434551 | Nenniger et al. | May 2013 | B2 |
| 8455405 | Chakrabarty | Jun 2013 | B2 |
| 8474531 | Nasr et al. | Jul 2013 | B2 |
| 8528642 | Boone | Sep 2013 | B2 |
| 8596357 | Nenniger | Dec 2013 | B2 |
| 8602098 | Kwan et al. | Dec 2013 | B2 |
| 8616278 | Boone et al. | Dec 2013 | B2 |
| 8684079 | Wattenbarger et al. | Apr 2014 | B2 |
| 8752623 | Sirota et al. | Jun 2014 | B2 |
| 8770289 | Boone | Jul 2014 | B2 |
| 8776900 | Nenniger et al. | Jul 2014 | B2 |
| 8783358 | Critsinelis et al. | Jul 2014 | B2 |
| 8844639 | Gupta et al. | Sep 2014 | B2 |
| 8857512 | Nenniger et al. | Oct 2014 | B2 |
| 8899321 | Dawson et al. | Dec 2014 | B2 |
| 8985205 | Nenniger | Mar 2015 | B2 |
| 9103205 | Wright et al. | Aug 2015 | B2 |
| 9115577 | Alvestad et al. | Aug 2015 | B2 |
| 9316096 | Bang et al. | Apr 2016 | B2 |
| 9341049 | Hailey, Jr. et al. | May 2016 | B2 |
| 9347312 | Vincelette et al. | May 2016 | B2 |
| 9359868 | Scott | Jun 2016 | B2 |
| 9394769 | Nenniger | Jul 2016 | B2 |
| 9488040 | Chakrabarty et al. | Nov 2016 | B2 |
| 9506332 | Saeedfar | Nov 2016 | B2 |
| 9644467 | Chakrabarty | May 2017 | B2 |
| 9739123 | Wheeler et al. | Aug 2017 | B2 |
| 9809786 | Olson et al. | Nov 2017 | B2 |
| 9845669 | Miller et al. | Dec 2017 | B2 |
| 9951595 | Akinlade et al. | Apr 2018 | B2 |
| 9970282 | Khaledi et al. | May 2018 | B2 |
| 9970283 | Khaledi et al. | May 2018 | B2 |
| 10000998 | Chakrabarty et al. | Jun 2018 | B2 |
| 10041340 | Chakrabarty | Aug 2018 | B2 |
| 10094208 | Hoier et al. | Oct 2018 | B2 |
| 10145226 | Yee et al. | Dec 2018 | B2 |
| 20010009830 | Bachar | Jul 2001 | A1 |
| 20010017206 | Davidson et al. | Aug 2001 | A1 |
| 20010018975 | Richardson et al. | Sep 2001 | A1 |
| 20020029881 | de Rouffignac et al. | Mar 2002 | A1 |
| 20020033253 | de Rouffignac et al. | Mar 2002 | A1 |
| 20020038710 | Maher et al. | Apr 2002 | A1 |
| 20020040779 | Wellington et al. | Apr 2002 | A1 |
| 20020046838 | Karanikas et al. | Apr 2002 | A1 |
| 20020056551 | Wellington et al. | May 2002 | A1 |
| 20020104651 | McClung, III | Aug 2002 | A1 |
| 20020148608 | Shaw | Oct 2002 | A1 |
| 20020157831 | Kurlenya et al. | Oct 2002 | A1 |
| 20030000711 | Gutek et al. | Jan 2003 | A1 |
| 20030009297 | Mirotchnik et al. | Jan 2003 | A1 |
| 20060231455 | Olsvik et al. | Oct 2006 | A1 |
| 20080017372 | Gates | Jan 2008 | A1 |
| 20080115945 | Lau et al. | May 2008 | A1 |
| 20080153717 | Pomerleau et al. | Jun 2008 | A1 |
| 20080173447 | Da Silva et al. | Jul 2008 | A1 |
| 20090288826 | Gray | Nov 2009 | A1 |
| 20100258308 | Speirs et al. | Oct 2010 | A1 |
| 20100276140 | Edmunds et al. | Nov 2010 | A1 |
| 20100276341 | Speirs et al. | Nov 2010 | A1 |
| 20100276983 | Dunn et al. | Nov 2010 | A1 |
| 20100282593 | Speirs et al. | Nov 2010 | A1 |
| 20110229071 | Vincelette et al. | Sep 2011 | A1 |
| 20110272152 | Kaminsky et al. | Nov 2011 | A1 |
| 20110272153 | Boone et al. | Nov 2011 | A1 |
| 20110276140 | Vresilovic et al. | Nov 2011 | A1 |
| 20110303423 | Kaminsky et al. | Dec 2011 | A1 |
| 20120234535 | Dawson et al. | Sep 2012 | A1 |
| 20120285700 | Scott | Nov 2012 | A1 |
| 20130000896 | Boone | Jan 2013 | A1 |
| 20130000898 | Boone | Jan 2013 | A1 |
| 20130025861 | Kift et al. | Jan 2013 | A1 |
| 20130043025 | Scott | Feb 2013 | A1 |
| 20130045902 | Thompson et al. | Feb 2013 | A1 |
| 20130098607 | Kerr | Apr 2013 | A1 |
| 20130105147 | Scott | May 2013 | A1 |
| 20130112408 | Oxtoby | May 2013 | A1 |
| 20130153215 | Scott et al. | Jun 2013 | A1 |
| 20130153216 | Scott | Jun 2013 | A1 |
| 20130199777 | Scott | Aug 2013 | A1 |
| 20130199779 | Scott | Aug 2013 | A1 |
| 20130199780 | Scott | Aug 2013 | A1 |
| 20130206405 | Kift et al. | Aug 2013 | A1 |
| 20130328692 | Johannessen | Dec 2013 | A1 |
| 20140034305 | Dawson | Feb 2014 | A1 |
| 20140048259 | Menard | Feb 2014 | A1 |
| 20140054028 | Little et al. | Feb 2014 | A1 |
| 20140069641 | Kosik | Mar 2014 | A1 |
| 20140083694 | Scott et al. | Mar 2014 | A1 |
| 20140083706 | Scott et al. | Mar 2014 | A1 |
| 20140096959 | Hocking | Apr 2014 | A1 |
| 20140144627 | Salazar Hernandez et al. | May 2014 | A1 |
| 20140174744 | Boone et al. | Jun 2014 | A1 |
| 20140251596 | Gittins et al. | Sep 2014 | A1 |
| 20150034555 | Speirs et al. | Feb 2015 | A1 |
| 20150053401 | Khaledi et al. | Feb 2015 | A1 |
| 20150083413 | Salazar et al. | Mar 2015 | A1 |
| 20150107833 | Boone et al. | Apr 2015 | A1 |
| 20150107834 | Shen et al. | Apr 2015 | A1 |
| 20150144345 | Bilozir et al. | May 2015 | A1 |
| 20160061014 | Sood et al. | Mar 2016 | A1 |
| 20160153270 | Chen et al. | Jun 2016 | A1 |
| 20170051597 | Akiya et al. | Feb 2017 | A1 |
| 20170130572 | Yuan et al. | May 2017 | A1 |
| 20170210972 | Williamson et al. | Jul 2017 | A1 |
| 20170241250 | Singh et al. | Aug 2017 | A1 |
| 20180030381 | Olson et al. | Feb 2018 | A1 |
| 20180073337 | Park et al. | Mar 2018 | A1 |
| 20180265768 | Williamson | Sep 2018 | A1 |
| 20190002755 | Wang et al. | Jan 2019 | A1 |
| 20190032460 | Khaledi et al. | Jan 2019 | A1 |
| 20190032462 | Motahhari et al. | Jan 2019 | A1 |
| 20190063199 | Doraiswamy et al. | Feb 2019 | A1 |
| 20190119577 | Witham et al. | Apr 2019 | A1 |
| 20190120043 | Gupta et al. | Apr 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 0603924 | Aug 1960 | CA |
| 0836325 | Mar 1970 | CA |
| 0852003 | Sep 1970 | CA |
| 0956885 | Oct 1974 | CA |
| 0977675 | Nov 1975 | CA |
| 1015656 | Aug 1977 | CA |
| 1027851 | Mar 1978 | CA |
| 1059432 | Jul 1979 | CA |
| 1061713 | Sep 1979 | CA |
| 1072442 | Feb 1980 | CA |
| 1295118 | Feb 1992 | CA |
| 1300000 | May 1992 | CA |
| 2108723 | Apr 1995 | CA |
| 2108349 | Aug 1996 | CA |
| 2369244 | Apr 2005 | CA |
| 2147079 | Oct 2006 | CA |
| 2235085 | Jan 2007 | CA |
| 2281276 | Feb 2007 | CA |
| 2647973 | Oct 2007 | CA |
| 2304938 | Feb 2008 | CA |
| 2299790 | Jul 2008 | CA |
| 2633061 | Jul 2008 | CA |
| 2374115 | May 2010 | CA |
| 2652930 | Jul 2010 | CA |
| 2621991 | Sep 2010 | CA |
| 2660227 | Sep 2010 | CA |
| 2730875 | Aug 2012 | CA |
| 2971941 | Dec 2012 | CA |
| 2436158 | Jun 2013 | CA |
| 2553297 | Jul 2013 | CA |
| 2654848 | Oct 2013 | CA |
| 2777966 | Nov 2013 | CA |
| 2781273 | May 2014 | CA |
| 2804521 | Jul 2014 | CA |
| 2917260 | Jan 2015 | CA |
| 2917263 | Jan 2015 | CA |
| 2841520 | Feb 2015 | CA |
| 2785871 | May 2015 | CA |
| 2691399 | Sep 2015 | CA |
| 2847759 | Sep 2015 | CA |
| 2893170 | Nov 2015 | CA |
| 2853445 | Dec 2015 | CA |
| 2854171 | Dec 2015 | CA |
| 2898065 | Jan 2016 | CA |
| 2962274 | Jan 2016 | CA |
| 2890491 | Feb 2016 | CA |
| 2893221 | Apr 2016 | CA |
| 2872120 | May 2016 | CA |
| 2875846 | May 2016 | CA |
| 2900179 | May 2016 | CA |
| 2898943 | Jun 2016 | CA |
| 2897785 | Jul 2016 | CA |
| 2900178 | Sep 2016 | CA |
| 2707776 | Nov 2016 | CA |
| 2893552 | Nov 2016 | CA |
| 2935652 | Jan 2017 | CA |
| 2857329 | Feb 2017 | CA |
| 2915571 | Feb 2017 | CA |
| 2856460 | May 2017 | CA |
| 2956771 | Aug 2017 | CA |
| 2981619 | Dec 2017 | CA |
| 2875848 | May 2018 | CA |
| 2899805 | May 2018 | CA |
| 2928044 | Jul 2018 | CA |
| 2974714 | Sep 2018 | CA |
| 2965117 | Oct 2018 | CA |
| 2958715 | Mar 2019 | CA |
| 101870894 | Apr 2009 | CN |
| 0144203 | Jun 1985 | EP |
| 0261793 | Mar 1988 | EP |
| 0283602 | Sep 1988 | EP |
| 0747142 | Apr 2001 | EP |
| 2852713 | Sep 2004 | FR |
| 1457696 | Dec 1976 | GB |
| 1463444 | Feb 1977 | GB |
| 2156400 | Oct 1985 | GB |
| 2164978 | Apr 1986 | GB |
| 2286001 | Oct 1995 | GB |
| 2357528 | Jun 2001 | GB |
| 2391890 | Feb 2004 | GB |
| 2391891 | Feb 2004 | GB |
| 2403443 | Jan 2005 | GB |
| 20130134846 | May 2012 | KR |
| 198201214 | Apr 1982 | WO |
| 198912728 | Dec 1989 | WO |
| 199421889 | Sep 1994 | WO |
| 199967503 | Dec 1999 | WO |
| 200025002 | May 2000 | WO |
| 200066882 | Nov 2000 | WO |
| 200181239 | Nov 2001 | WO |
| 200181715 | Nov 2001 | WO |
| 200192673 | Dec 2001 | WO |
| 200192768 | Dec 2001 | WO |
| 2002086018 | Oct 2002 | WO |
| 2002086276 | Oct 2002 | WO |
| 2003010415 | Feb 2003 | WO |
| 2003036033 | May 2003 | WO |
| 2003036038 | May 2003 | WO |
| 2003036039 | May 2003 | WO |
| 2003036043 | May 2003 | WO |
| 2003038233 | May 2003 | WO |
| 2003040513 | May 2003 | WO |
| 2003062596 | Jul 2003 | WO |
| 2004038173 | May 2004 | WO |
| 2004038174 | May 2004 | WO |
| 2004038175 | May 2004 | WO |
| 2004050567 | Jun 2004 | WO |
| 2004050791 | Jun 2004 | WO |
| 2004097159 | Nov 2004 | WO |
| 2005012688 | Feb 2005 | WO |
| 2015158371 | Oct 2015 | WO |
| 2017222929 | Dec 2017 | WO |
| Entry |
|---|
| Ai-Gosayier, M., et al. (2015) “In Situ Recovery of Heavy-Oil From Fractured Carbonate Reservoirs: Optimization of Steam-Over-Solvent Injection Method” Journal of Petroleum Science and Engineering, vol. 130, pp. 77-85. |
| Andrade, M.R., et al. (2007), “Mixotrophic cultivation of microalga Spirulina platensis using molasses as organic substrate”, Aquaculture, vol. 264, pp. 130-134. |
| Bayestehparvin, B., et al. (2015) “Dissolution an dMobilization of Bitumen at Pore Scale”, SPE174482-MS, Prepared for presentation at the SPE Canada Heavy Oil Technical Conference held in Calgary, Alberta, Canada, Jun. 9-11, 2015; 23 pages. |
| Butler, R. M. et al. (1991) “A new process (VAPEX) for recovering heavy oils using hot water and hydrocarbon vapour”, CIM/SPE Annual Technical Conference Jan.-Feb. vol. 30, No. 1, pp. 97-106. |
| Butler, R. M. et al. (1993) “Recovery of Heavy Oils Using Vapourized Hydrocarbon Solvents: Further Development of the Vapex Process” The Journal of Canadian Petroleum Technology, June, vol. 32, No. 6, pp. 56-64. |
| Castanier, L.M., et al. (2005) “Heavy oil upgrading in-situ via solvent injection andcombustion: A “new” method”, EAGE 67th Conference & Exhibition—Madrid, Spain, Jun. 13-16, 2005; 4 pages. |
| Cristofari, J., et al. (2008) “Laboratory Investigation of the Effect of Solvent Injection on In-Situ Combustion” SPE 99752 prepared for presentation at the 2006 SPE/DOE Symposium on Improved Oil Recovery, Tulsa, Apr. 22-26. 11 pages. |
| Cunha, L.B. (2005) “Recent In-Situ Oil Recovery-Technologies for Heavy- and Extraheavy-Oil Reserves”, SPE 94986, prepared for presentation at the 2005 SPE Latin American and Caribbean Petroleum Enginerring Conference held in Rio de Janeiro, Brazil, Jun. 20-23; 5 pages. |
| Deng, X (2005) “Recovery Performance and Economics of Steam/Propane Hybrid Process.” SPE/PS-CIM/CHOA 97760, PS2005-341, SPE/PS-CIM/CHOA International Thermal Operations and Heavy Oil Symposium, copyright, pp. 1-7. |
| Diaz, J. A. D. (2006) “An Experimental Study of Steam and Steam-Propane Injection Using a Novel Smart Horizontal Producer to Enhance Oil Production in the San Ardo Field.” Presentation given at Sponsor's Meeting, Crisman Institute, Aug. 3, Department of Petroleum Engineering, Texas A&M University (7 pages). |
| Doan, Q., et al. (2011) “Potential Pitfalls From Successful History-Match Simulation of a Long-Running Clearwater-Fm Sagd Well Pair” SPE 147318, Prepared for presentation at the SPE Annual Technical Conference and Exhibition held in Denver, Colorado, Oct. 30-Nov. 2; 9 pages. |
| D'Silva, J, et al. (2008) “In-Situ Combustion With Solvent Injection” SPE 117684, Prepared for presentation at the SPE International Thermal Operations and Heavy Oil Symposium held in Calgary, Alberta, Canada, Oct. 20-23; 11 pages. |
| D'Silva, J., et al. (2011) “Integration of In-Situ Combustion With Solvent Injection—A Detailed Study” SPE 141570, Prepared for presentation at the SPE Projects and Facilities Challenges Conference at METS held in Doha, Qatar, Feb. 13-16; 11 pages. |
| Dunn-Norman, S., et al. (2002) “Recovery Methods for Heavy Oil in Ultra-Shallow Reservoirs” SPE 76710, prepared for presentation at the SPE Western Regional/AAPG Pacific Section Joint Meeting held in Anchorage, Alaska, May 20-22, 6 pages. |
| Frauenfeld, T.W., et al (2006) “Economic Analysis of Thermal Solvent Processes” Pet-Soc 2006-164; Presented at the Petroleum Socity's 7th Canadian International Peteroleum Conference (57th Annual Technical Meeting), Calgary, Alberta, Canada, Jun. 13-15, 2006; 9 pages. |
| Gates, I.D., et al. (2011) “Evolution of In Situ Oil Sands Recovery Technology: What Happened and What's New?” SPE150686, Prepared for presentation at the SPE Heavy Oil Conference and Exhibition held in Kuwait City, Kuwait, Dec. 12-14, 2011; 10 pages. |
| Ghoodjani, E., et al. (2012) “A Review on Thermal Enhanced Heavy Oil Recovery From Fractured Carbonate Reservoirs” SPE 150147, Prepared for presentation at the SPE Heavy Oil Conference Canada held in Calgary, Alberta, Canada, Jun. 12-14, 2012; 8 pages. |
| Goldthorpe, S. (2013) “Cement Plant CO2 to DME,” IEAGHG Information Paper; 2013-IP9, Jun. 2013, 1 page. |
| Greaser, G.R., et al. (2003) “New Thermal Recovery Tech nology and Technology Transfer for Successful Heavy Oil Development.” SPE69731, Society of Petroleum Engineers, Inc., 7 pages. |
| Hong, K.C. (1999) “Recent Advances in Steamflood Technology.” SPE 54078, Copyright 1999, Society of Petroleum Engineers, Inc., 14 pages. |
| Jaiswal, N. J. (2006) “Experimental and Analytical Studies of Hydrocarbon Yields Under Dry-, Steam-, and Steam with Propane-Distillation.” Presentation given at Crisman Institute's Halliburton Center for Unconventional Resources, Aug. 3, 2006, Department of Petroleum Engineering, Texas A&M University (5 pages). |
| Jiang, Q., et al. (2010) “Evaluation of Recovery Technologies for the Grosmont Carbonate Reservoirs” Journal of Canadian Petroleum Technology, vol. 49, No. 5, pp. 56-64. |
| Kamal, C., et al. (2012), “Spirulina platensis—A novel green inhibitor for acid corrosion of mild steel”, Arabian Journal of Chemistry, vol. 5, pp. 155-161. |
| Khaledi, R., et al. (2018) “Azeotropic Heated Vapour Extraction—A New Thermal-Solvent Assisted Gravity Drainage Recovery Process”, SPE189755-MS, SPE Canada Heavy Oil Technical Conference held in Calgary, Alberta, Canada, Mar. 13-14, 2018, 20 pages. |
| Lei, H., et al. (2012) “An Evaluation of Air Injection as a Follow-Up Process to Cyclic Steam Stimulation in a Heavy Oil Reservoir” SPE 150703, Prepared for presentation at the SPE Heavy Oil Conference Canada held in Calgary, Alberta, Canada, Jun. 12-14, 2012; 13 pages. |
| Lennox, T.R. et al (1980) “Geology of In Situ Pilot Project, Wabasca Oil Sands Deposit, Alberta” Saskatchewan Geological Society Special Publication No. 5; Conference and Core Seminar, Regina, Oct. 15-17, 1980; pp. 267-268. |
| Lim, G.B. et al. (1994) “Three Dimensional Scaled Physcial Modeling of Solvent Vapour Extraction of Cold Lake Bitumen,” Canadian SPE Int'l Conf. on Recent Advances in Horizontal Well Applications, Paper No. HWC94-46, Calgary, Canada, Mar. 20-23, 1994, 11 pages. |
| Lim, G.B. et al. (1995) “Cyclic Stimulation of Cold Lake Oil Sand with Supercriticall Ethane,” SPE #30298, Int'l Heavy Oil Symposium, Calgary, Alberta, Canada, Jun. 19-21, 1995, pp. 521-528. |
| Lyubovsky, M., et al. (2005) “Catalytic Partial ‘Oxidation of Methane to Syngas’ at Elevated Pressures,” Catalysis Letters, v. 99, Nos. 3-4, Feb. 2005, pp. 113-117. |
| Mamora, D. D., (2006) “Thermal Oil Recovery Research at Texas A&M in the Past Five Years—an Overview.” Presentation given at the Crisman Institute Halliburton Center for Unconventional Resources, Research Meeting Aug. 3, Department of Petroleum Engineering, Texas A&M University (13 pages). |
| Mert, B.D., et al. (2011) “The role of Spirulina platensis on corrosion behavior of carbon steel”, Materials Chemistry and Physics, vol. 130, pp. 697-701. |
| Mokrys, I. J., et al. (1993) “In-Situ Upgrading of Heavy Oils andBitumen by Propane Deasphalting: The Vapex Process” SPE 25452, Mar. 21-23, Oklahoma City, OK, pp. 409-424. |
| Mulac, A.J.,et al. (1981) “Project Deep Steam Preliminary Field Test Bakersfield, California.” SAND80-2843, Printed Apr. 62 pages. |
| Naderi, K., et al. (2015) “Effect of Bitumen Viscosity and Bitumen—Water Interfacial Tension on Steam Assisted Bitumen Recovery Process Efficiency”, Journal of Petroleum Science and Engineering 133, pp. 862-868. |
| Nasr, T.N., et al. (2005) “Thermal Techniques for the Recovery of Heavy Oil and Bitumen” SPE 97488 prepared for presentation at the SPE International Improved Oil Recovery Conferencein Asia Pacific held in Kuala Lumpur, Malaysia, Dec. 5-6, 2005. 15 pages. |
| Nasr, T.N. et al. (2006) “New Hybrid Steam-Solvent Processes for the Recovery of Heavy Oil and Bitumen” SPE 101717 Prepared for presentation at the Abu Dhabi International Petroleum Exhibition and Conference held in Abu Dhabi, U.A.E., Nov. 5-8, 2006; 17 pages. |
| National Energy Board, (2004) “Canada's Oil Sands. Opportunities and Challenges to 2015.” An Energy Market Assessment, May (158 pages). |
| Nexant, Inc. (2008), “Dimethyl Ether Technology and Markets,” CHEMSystems PERP Program Report 07/08S3, Dec. 2008, 7 pages. |
| NTIS, Downhole Steam-Generator Study, vol. 1, Conception and Feasibility Evaluation. Final Report, Sep. 1978-Sep. 1980, Sandia National Labs, Albuquerque NM, Jun. 1982. 260 pages. |
| Oceaneering; Website: http://www.oceaneering.com/Brochures/MFX%20%Oceaneering%20Multiflex.pdf, Oceaneering Multiflex, Oceaneering International, Incorporated, printed Nov. 23, 2005, 2 pages. |
| Qi, G.X. et al. (2001) “DME Synthesis from Carbon Dioxide and Hydrogen Over Cu—Mo/HZSM-5,” Catalysis Letters, V. 72, Nos. 1-2, 2001, pp. 121-124. |
| Redford, et al. (1980) “Hydrocarbon-Steam Processes for Recovery of Bitumen from Oil Sands” SPE8823, Prepared for presentation at the First Joint SPE/DOE Symposium on Enhanced Oil Recovery at Tulsa, Oklahoma, Apr. 20-23; 12 pages. |
| Saeedfar, A., et al. (2018) “Critical Consideration for Analysis of RF-Thermal Recovery of Heavy Petroleum” SPE-189714-MS, Prepared for presentation at the SPE Canada Heavy Oil Technical Conference held in Calgary, Alberta, Canada, Mar. 13-14, 2018; 13 pages. |
| Seibert, B. H. (2012) “Sonic Azeotropic Gravity Extraction of Heavy Oil From Oil Sands”, SPE157849-MS, SPE Heavy Oil Conference Canda held in Calgary, Alberta, Canada, Jun. 12-14, 2012, 10 pages. |
| Sharma, J. et al. (2010) “Steam-Solvent Coupling at the Chamber Edge in an In Situ Bitumen Recovery Process” SPE 128045, Prepared for presentation at the SPE Oil and Gas India Conference and Exhibition held in Mumbai, India Jan. 20-22; 26 pages. |
| Stark, S.D. (2013) “Cold Lake Commercialization of the Liquid Addition to Steam for Enhancing Recovery (Laser) Process” IPTC 16795, Prepared for presentation at the International Petroleum Technology Conference held in Beijing, China, Mar. 26-28, 2013, 15 pages. |
| Wan Nik, W.B., et al. (2012), “Marine Extracts as Corrosion Inhibitor for Aluminum in Seawater Applications”, International Journal of Engineering Research and Applications (IJERA), vol. 2, Issue 1; pp. 455-458. |
| Zhang, L. et al. (2013) “Dehydration of Methanol to Dimethyl Ether Over y—Al2O3 Catalyst: Intrinsic Kinetics and Effectiveness Factor,” Canadian Journal of Chem. Engineering, v.91, Sep. 2013, pp. 1538-1546. |
| International Search Report and the Written Opinion of the International Searching Authority, or the Declaration (2 pages), International Search Report (4 pages), and Written Opinion of the International Searching Authority (6 pages) for International Application No. PCT/US2007/080985 dated Feb. 28, 2008. |
| International Preliminary Report on Patentability (2 pages); Written Opinion of the International Searching Authority (6 pages); all dated Apr. 23, 2009 in PCT International Application No. PCT/US2007/080985 filed Oct. 10, 2007 (Total 8 pages). |
| Number | Date | Country | |
|---|---|---|---|
| 20190063199 A1 | Feb 2019 | US |
